BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ;  MADIT II Investigators. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol. 2008;51:1357-1365. [PMID: 18387436 DOI: 10.1016/j.jacc.2007.09.073] [Cited by in Crossref: 585] [Cited by in F6Publishing: 322] [Article Influence: 45.0] [Reference Citation Analysis]
Number Citing Articles
1 Datta T, Melnick S, Rajaram B, Pavri BB. A Shocking Case of Far-Field Atrial Oversensing in Giant-Cell Myocarditis. JACC Case Rep 2021;3:603-9. [PMID: 34317586 DOI: 10.1016/j.jaccas.2021.02.041] [Reference Citation Analysis]
2 Neder JA, Rocha A, Alencar MCN, Arbex F, Berton DC, Oliveira MF, Sperandio PA, Nery LE, O'Donnell DE. Current challenges in managing comorbid heart failure and COPD. Expert Rev Cardiovasc Ther 2018;16:653-73. [PMID: 30099925 DOI: 10.1080/14779072.2018.1510319] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
3 Boveda S, Marijon E, Jacob S, Defaye P, Winter JB, Bulava A, Gras D, Albenque JP, Combes N, Pavin D. Incidence and prognostic significance of sustained ventricular tachycardias in heart failure patients implanted with biventricular pacemakers without a back-up defibrillator: results from the prospective, multicentre, Mona Lisa cohort study. Eur Heart J. 2009;30:1237-1244. [PMID: 19264750 DOI: 10.1093/eurheartj/ehp071] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
4 Nielsen JC, Lin YJ, de Oliveira Figueiredo MJ, Sepehri Shamloo A, Alfie A, Boveda S, Dagres N, Di Toro D, Eckhardt LL, Ellenbogen K, Hardy C, Ikeda T, Jaswal A, Kaufman E, Krahn A, Kusano K, Kutyifa V, Lim HS, Lip GYH, Nava-Townsend S, Pak HN, Rodríguez Diez G, Sauer W, Saxena A, Svendsen JH, Vanegas D, Vaseghi M, Wilde A, Bunch TJ, Buxton AE, Calvimontes G, Chao TF, Eckardt L, Estner H, Gillis AM, Isa R, Kautzner J, Maury P, Moss JD, Nam GB, Olshansky B, Pava Molano LF, Pimentel M, Prabhu M, Tzou WS, Sommer P, Swampillai J, Vidal A, Deneke T, Hindricks G, Leclercq C; ESC Scientific Document Group. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population. Europace 2020;22:1147-8. [PMID: 32538434 DOI: 10.1093/europace/euaa065] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 22.0] [Reference Citation Analysis]
5 Zaman S, Kovoor P. Sudden cardiac death early after myocardial infarction: pathogenesis, risk stratification, and primary prevention. Circulation 2014;129:2426-35. [PMID: 24914016 DOI: 10.1161/CIRCULATIONAHA.113.007497] [Cited by in Crossref: 55] [Cited by in F6Publishing: 13] [Article Influence: 7.9] [Reference Citation Analysis]
6 El-damaty A, Sapp JL. The role of catheter ablation for ventricular tachycardia in patients with ischemic heart disease. Current Opinion in Cardiology 2011;26:30-9. [DOI: 10.1097/hco.0b013e328341390b] [Cited by in Crossref: 6] [Article Influence: 0.6] [Reference Citation Analysis]
7 Shah H, Mezu U, Patel D, Flanigan S, Hreybe H, Adelstein E, Jain S, Lang V, Saba S. Mechanisms of Inappropriate Defibrillator Therapy in a Modern Cohort of Remotely Monitored Patients: MECHANISMS OF INAPPROPRIATE ICD THERAPY. Pacing and Clinical Electrophysiology 2013;36:547-52. [DOI: 10.1111/pace.12101] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
8 Asirvatham SJ. Innovation focus: the patient with arrhythmia. J Cardiovasc Transl Res 2008;1:258-72. [PMID: 20559933 DOI: 10.1007/s12265-008-9061-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Schukro C, Leitner L, Siebermair J, Pezawas T, Stix G, Kastner J, Schmidinger H. Impact of accelerated ventricular tachyarrhythmias on mortality in patients with implantable cardioverter-defibrillator therapy. International Journal of Cardiology 2013;167:3006-10. [DOI: 10.1016/j.ijcard.2012.09.015] [Cited by in Crossref: 26] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
10 Piccini JP, Hellkamp AS, Whellan DJ, Ellis SJ, Keteyian SJ, Kraus WE, Hernandez AF, Daubert JP, Piña lL, O'Connor CM; HF-ACTION Investigators. Exercise training and implantable cardioverter-defibrillator shocks in patients with heart failure: results from HF-ACTION (Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing). JACC Heart Fail 2013;1:142-8. [PMID: 23936756 DOI: 10.1016/j.jchf.2013.01.005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
11 Hindricks G, Taborsky M, Glikson M, Heinrich U, Schumacher B, Katz A, Brachmann J, Lewalter T, Goette A, Block M, Kautzner J, Sack S, Husser D, Piorkowski C, Søgaard P. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. The Lancet 2014;384:583-90. [DOI: 10.1016/s0140-6736(14)61176-4] [Cited by in Crossref: 404] [Cited by in F6Publishing: 99] [Article Influence: 57.7] [Reference Citation Analysis]
12 Albatat M, Bergsland J, Arevalo H, Odland HH, Bose P, Halvorsen PS, Balasingham I. Technological and Clinical Challenges in Lead Placement for Cardiac Rhythm Management Devices. Ann Biomed Eng 2020;48:26-46. [DOI: 10.1007/s10439-019-02376-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Bunch TJ, Day JD, Olshansky B, Stolen KQ, Mullin CM. Newly detected atrial fibrillation in patients with an implantable cardioverter-defibrillator is a strong risk marker of increased mortality. Heart Rhythm 2009;6:2-8. [DOI: 10.1016/j.hrthm.2008.09.025] [Cited by in Crossref: 44] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
14 Ayan M, Habash F, Alqam B, Gheith Z, Cross M, Vallurupalli S, Paydak H. A comparison of anti-arrhythmic efficacy of carvedilol vs metoprolol succinate in patients with implantable cardioverter-defibrillators. Clin Cardiol 2019;42:299-304. [PMID: 30592068 DOI: 10.1002/clc.23144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Bencardino G, Di Monaco A, Rio T, Frontera A, Santangeli P, Leo M, Pelargonio G, Perna F, Narducci ML, Gabrielli F, Lanza GA, Bellocci F, Rebuzzi A, Crea F. The Association Between ICD Interventions and Mortality is Independent of their Modality: Clinical Implications: ICD Interventions and Mortality. J Cardiovasc Electrophysiol 2014;25:1363-7. [DOI: 10.1111/jce.12499] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
16 Maytin M, Epstein LM. Relationship Between Sprint Fidelis Leads and Patient Mortality. Journal of the American College of Cardiology 2012;59:193-4. [DOI: 10.1016/j.jacc.2011.07.052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
17 Strickberger SA, Canby R, Cooper J, Coppess M, Doshi R, John R, Connolly AT, Roberts G, Karst E, Daoud EG. Association of Antitachycardia Pacing or Shocks With Survival in 69,000 Patients With an Implantable Defibrillator: ATP and Mortality in 69,000 ICD Patients. J Cardiovasc Electrophysiol 2017;28:416-22. [DOI: 10.1111/jce.13170] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 6.8] [Reference Citation Analysis]
18 Nair GM, Healey JS, Divakaramenon SM, Connolly SJ, Morillo CA. Antiarrhythmic Drug Therapy for New-Onset Ventricular Arrhythmia (VT/VF) in ICD Patients. Cardiac Electrophysiology Clinics 2011;3:651-61. [DOI: 10.1016/j.ccep.2011.08.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
19 Bandera F, Baghdasaryan L, Mandoli GE, Cameli M. Multimodality imaging predictors of sudden cardiac death. Heart Fail Rev 2020;25:427-46. [PMID: 31792657 DOI: 10.1007/s10741-019-09893-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
20 Sodhi SS, Cedars AM. Primary Prevention of Sudden Cardiac Death in Adults with Transposition of the Great Arteries: A Review of Implantable Cardioverter-Defibrillator Placement. Tex Heart Inst J 2015;42:309-18. [PMID: 26413012 DOI: 10.14503/THIJ-14-4352] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Santini M, Lunati M, Defaye P. Prospective multicenter randomized trial of fast ventricular tachycardia termination by prolonged versus conventional anti-tachyarrhythmia burst pacing in implantable cardioverter-defibrillator patients-Atp DeliVery for pAiNless ICD therapy (ADVANCED-D) Trial results. J Interv Card Electrophysiol. 2010;27:127-135. [PMID: 20087760 DOI: 10.1007/s10840-009-9454-z] [Cited by in Crossref: 38] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
22 Perings C, Bauer WR, Bondke HJ, Mewis C, James M, Böcker D, Broadhurst P, Korte T, Toft E, Hintringer F, Clémenty J, Schwab JO. Remote monitoring of implantable-cardioverter defibrillators: results from the Reliability of IEGM Online Interpretation (RIONI) study. Europace 2011;13:221-9. [PMID: 21252195 DOI: 10.1093/europace/euq447] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
23 Battipaglia I, Barone L, Mariani L, Infusino F, Remoli R, Careri G, Pinnacchio G, Tarzia P, Lanza GA, Crea F. Relationship between cardiac autonomic function and sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillators. Europace 2010;12:1725-31. [DOI: 10.1093/europace/euq408] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
24 Chen B, Liu Q, Wang X, Dang A. Are dual-chamber implantable cardioverter-defibrillators really better than single-chamber ones? A systematic review and meta-analysis. J Interv Card Electrophysiol 2014;39:273-80. [DOI: 10.1007/s10840-014-9873-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
25 Greenlee RT, Go AS, Peterson PN, Cassidy-Bushrow AE, Gaber C, Garcia-Montilla R, Glenn KA, Gupta N, Gurwitz JH, Hammill SC, Hayes JJ, Kadish A, Magid DJ, McManus DD, Multerer D, Powers JD, Reifler LM, Reynolds K, Schuger C, Sharma PP, Smith DH, Suits M, Sung SH, Varosy PD, Vidaillet HJ, Masoudi FA. Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter-Defibrillators in the Cardiovascular Research Network. J Am Heart Assoc 2018;7:e008292. [PMID: 29581222 DOI: 10.1161/JAHA.117.008292] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
26 Zannad F, Garcia AA, Anker SD, Armstrong PW, Calvo G, Cleland JG, Cohn JN, Dickstein K, Domanski MJ, Ekman I, Filippatos GS, Gheorghiade M, Hernandez AF, Jaarsma T, Koglin J, Konstam M, Kupfer S, Maggioni AP, Mebazaa A, Metra M, Nowack C, Pieske B, Piña IL, Pocock SJ, Ponikowski P, Rosano G, Ruilope LM, Ruschitzka F, Severin T, Solomon S, Stein K, Stockbridge NL, Stough WG, Swedberg K, Tavazzi L, Voors AA, Wasserman SM, Woehrle H, Zalewski A, McMurray JJ. Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document. Eur J Heart Fail 2013;15:1082-94. [PMID: 23787718 DOI: 10.1093/eurjhf/hft095] [Cited by in Crossref: 128] [Cited by in F6Publishing: 108] [Article Influence: 16.0] [Reference Citation Analysis]
27 Knops RE, Kooiman KM, Ten Sande JN, de Groot JR, Wilde AA. First experience with the wearable cardioverter defibrillator in the Netherlands. Neth Heart J 2012;20:77-81. [PMID: 22144231 DOI: 10.1007/s12471-011-0227-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
28 Aizawa Y, Takatsuki S, Negishi M, Kashimura S, Katsumata Y, Nishiyama T, Kimura T, Nishiyama N, Tanimoto Y, Tanimoto K, Kohsaka S, Sano M, Fukuda K. Clinical characteristics of atrial fibrillation detected by implanted devices and its association with ICD therapy. International Journal of Cardiology 2014;172:e529-30. [DOI: 10.1016/j.ijcard.2014.01.067] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 2.4] [Reference Citation Analysis]
29 Sivagangabalan G, Chik W, Zaman S, Stafford W, Hayes J, Denman R, Young G, Sanders P, Kovoor P. Antitachycardia Pacing for Very Fast Ventricular Tachycardia and Low-Energy Shock for Ventricular Arrhythmias in Patients With Implantable Defibrillators. The American Journal of Cardiology 2013;112:1153-7. [DOI: 10.1016/j.amjcard.2013.06.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
30 Cay S, Canpolat U, Ucar F, Ozeke O, Ozcan F, Topaloglu S, Aras D. Programming Implantable Cardioverter-Defibrillator Therapy Zones to High Ranges to Prevent Delivery of Inappropriate Device Therapies in Patients With Primary Prevention: Results from the RISSY-ICD (Reduction of Inappropriate ShockS bY InCreaseD zones) trial. The American Journal of Cardiology 2015;115:1235-43. [DOI: 10.1016/j.amjcard.2015.01.558] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
31 Canterbury A, Saba S. Cardiac resynchronization therapy using a pacemaker or a defibrillator: Patient selection and evidence to support it. Prog Cardiovasc Dis 2021;66:46-52. [PMID: 33865865 DOI: 10.1016/j.pcad.2021.04.003] [Reference Citation Analysis]
32 Mcgarry TJ, Narayan SM. Defining Arrhythmic Risk and Defibrillator Therapy in ARVC. Journal of the American College of Cardiology 2014;64:126-8. [DOI: 10.1016/j.jacc.2014.05.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
33 Sredniawa B, Mazurek M, Lenarczyk R, Kowalski O, Kowalczyk J, Kalarus Z. Early therapy following myocardial infarction: arguments for and against implantable cardioverter-defibrillators. Future Cardiol 2010;6:315-23. [PMID: 20462338 DOI: 10.2217/fca.10.15] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
34 Mustafa U, Dherange P, Reddy R, DeVillier J, Chong J, Ihsan A, Jones R, Duddyala N, Reddy P, Dominic P. Atrial Fibrillation Is Associated With Higher Overall Mortality in Patients With Implantable Cardioverter-Defibrillator: A Systematic Review and Meta-Analysis. J Am Heart Assoc 2018;7:e010156. [PMID: 30554547 DOI: 10.1161/JAHA.118.010156] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
35 Freedberg NA, Feldman A. Prognostic Significance of Implantable Defibrillator Shock: Are All Shocks Created Equal? Journal of Cardiovascular Electrophysiology 2012;23:741-3. [DOI: 10.1111/j.1540-8167.2012.02299.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
36 Hofer D, Steffel J, Hürlimann D, Haegeli L, Lüscher TF, Duru F, Eriksson U, Krasniqi N. Long-term incidence of inappropriate shocks in patients with implantable cardioverter defibrillators in clinical practice-an underestimated complication? J Interv Card Electrophysiol 2017;50:219-26. [PMID: 29177981 DOI: 10.1007/s10840-017-0297-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
37 Sherrid MV, Daubert JP. Risks and Challenges of Implantable Cardioverter-Defibrillators in Young Adults. Progress in Cardiovascular Diseases 2008;51:237-63. [DOI: 10.1016/j.pcad.2008.10.001] [Cited by in Crossref: 48] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
38 Burke MC, Aasbo JD, El-Chami MF, Weiss R, Dinerman J, Hanon S, Kalahasty G, Bass E, Gold MR. 1-Year Prospective Evaluation of Clinical Outcomes and Shocks: The Subcutaneous ICD Post Approval Study. JACC Clin Electrophysiol 2020;6:1537-50. [PMID: 33213814 DOI: 10.1016/j.jacep.2020.05.036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
39 Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009-1017. [PMID: 18768944 DOI: 10.1056/nejmoa071098] [Cited by in Crossref: 1015] [Cited by in F6Publishing: 151] [Article Influence: 78.1] [Reference Citation Analysis]
40 Loring Z, Zareba W, McNitt S, Strauss DG, Wagner GS, Daubert JP. ECG quantification of myocardial scar and risk stratification in MADIT-II. Ann Noninvasive Electrocardiol 2013;18:427-35. [PMID: 24047486 DOI: 10.1111/anec.12065] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
41 Proietti R, Labos C, Davis M, Thanassoulis G, Santangeli P, Russo V, Di Biase L, Roux JF, Verma A, Natale A, Essebag V. A systematic review and meta-analysis of the association between implantable cardioverter-defibrillator shocks and long-term mortality. Can J Cardiol 2015;31:270-7. [PMID: 25746019 DOI: 10.1016/j.cjca.2014.11.023] [Cited by in Crossref: 39] [Cited by in F6Publishing: 16] [Article Influence: 5.6] [Reference Citation Analysis]
42 Janardhan AH, Li W, Fedorov VV, Yeung M, Wallendorf MJ, Schuessler RB, Efimov IR. A novel low-energy electrotherapy that terminates ventricular tachycardia with lower energy than a biphasic shock when antitachycardia pacing fails. J Am Coll Cardiol 2012;60:2393-8. [PMID: 23141483 DOI: 10.1016/j.jacc.2012.08.1001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
43 Yousuf O, Spragg DD. ICD Therapy-Can We Make a Life-Saving Device Less Lethal?: Editorial Comment. J Cardiovasc Electrophysiol 2016;27:200-2. [DOI: 10.1111/jce.12883] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
44 González-enríquez S, Rodríguez-entem F, Expósito V, Castrillo-bustamante C, Canteli A, Solloso A, Madrazo I, Olalla JJ. Single-chamber ICD, single-zone therapy in primary and secondary prevention patients: the simpler the better? J Interv Card Electrophysiol 2012;35:343-9. [DOI: 10.1007/s10840-012-9735-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
45 Thijssen J, Borleffs CJ, van Rees JB, de Bie MK, van der Velde ET, van Erven L, Bax JJ, Cannegieter SC, Schalij MJ. Driving restrictions after implantable cardioverter defibrillator implantation: an evidence-based approach. Eur Heart J 2011;32:2678-87. [PMID: 21646229 DOI: 10.1093/eurheartj/ehr161] [Cited by in Crossref: 36] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
46 Mazurek JA, Jessup M. Understanding Heart Failure. Heart Failure Clinics 2017;13:1-19. [DOI: 10.1016/j.hfc.2016.07.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
47 Madhavan M, Friedman PA. Optimal Programming of Implantable Cardiac-Defibrillators. Circulation 2013;128:659-72. [DOI: 10.1161/circulationaha.112.000542] [Cited by in Crossref: 32] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
48 Hadid C, Almendral J, Ortiz M, Schwab JO, Janko S, Mischke K, Arribas F, Wolpert C, Ricci R, Adragao P, Cobo E, Navarro X, Quesada A. Incidence, Determinants, and Prognostic Implications of True Pleomorphism of Ventricular Tachycardia in Patients With Implantable Cardioverter-Defribillators: A Substudy of the DATAS Trial. Circ Arrhythm Electrophysiol 2011;4:33-42. [DOI: 10.1161/circep.110.957068] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
49 Lambiase PD, Srinivasan NT. Early experience with the subcutaneous ICD. Curr Cardiol Rep 2014;16:516. [PMID: 24994568 DOI: 10.1007/s11886-014-0516-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
50 Maruyama M, Yasuoka R, Nagano T, Nakazawa G, Noda T, Nitta T, Aizawa Y, Ohe T, Kurita T. Impact of atrial fibrillation/flutter on outcomes of patients with implantable cardioverter defibrillators: A sub-analysis of the Nippon Storm study. J Cardiol 2021;78:244-9. [PMID: 33941429 DOI: 10.1016/j.jjcc.2021.04.003] [Reference Citation Analysis]
51 Groh CA, Sharma S, Pelchovitz DJ, Bhave PD, Rhyner J, Verma N, Arora R, Chicos AB, Kim SS, Lin AC. Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator. Heart Rhythm. 2014;11:1361-1366. [PMID: 24755323 DOI: 10.1016/j.hrthm.2014.04.025] [Cited by in Crossref: 78] [Cited by in F6Publishing: 42] [Article Influence: 11.1] [Reference Citation Analysis]
52 Gold MR, Ahmad S, Browne K, Berg KC, Thackeray L, Berger RD. Prospective comparison of discrimination algorithms to prevent inappropriate ICD therapy: primary results of the Rhythm ID Going Head to Head Trial. Heart Rhythm 2012;9:370-7. [PMID: 21978966 DOI: 10.1016/j.hrthm.2011.10.004] [Cited by in Crossref: 44] [Cited by in F6Publishing: 15] [Article Influence: 4.4] [Reference Citation Analysis]
53 Younis A, Heist EK, McNitt S, Aktas MK, Rosero S, Goldenberg I, Kutyifa V. Predictors and outcomes of atrial tachyarrhythmia among patients with implantable defibrillators. Heart Rhythm 2020;17:553-9. [PMID: 31765809 DOI: 10.1016/j.hrthm.2019.11.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
54 Napp A, Stunder D, Maytin M, Kraus T, Marx N, Driessen S. Are patients with cardiac implants protected against electromagnetic interference in daily life and occupational environment? Eur Heart J 2015;36:1798-804. [DOI: 10.1093/eurheartj/ehv135] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 4.2] [Reference Citation Analysis]
55 Sweeney MO, Sherfesee L, DeGroot PJ, Wathen MS, Wilkoff BL. Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. Heart Rhythm. 2010;7:353-360. [PMID: 20185109 DOI: 10.1016/j.hrthm.2009.11.027] [Cited by in Crossref: 239] [Cited by in F6Publishing: 139] [Article Influence: 19.9] [Reference Citation Analysis]
56 Kobayashi Y. How to manage various arrhythmias and sudden cardiac death in the cardiovascular intensive care. J Intensive Care 2018;6:23. [PMID: 29686877 DOI: 10.1186/s40560-018-0292-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
57 Olde Nordkamp LR, Wilde AA, Tijssen JG, Knops RE, van Dessel PF, de Groot JR. The ICD for Primary Prevention in Patients With Inherited Cardiac Diseases: Indications, Use, and Outcome: A Comparison With Secondary Prevention. Circ: Arrhythmia and Electrophysiology 2013;6:91-100. [DOI: 10.1161/circep.112.975268] [Cited by in Crossref: 60] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
58 Zeitler EP, Al-Khatib SM, Friedman DJ, Han JY, Poole JE, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Dorian P, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Inoue LYT, Sanders GD. Predicting appropriate shocks in patients with heart failure: Patient level meta-analysis from SCD-HeFT and MADIT II. J Cardiovasc Electrophysiol 2017;28:1345-51. [PMID: 28744959 DOI: 10.1111/jce.13307] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
59 Sun S, Johnson J, Degroot P, Brown ML, Obel O. Effect of ICD Therapies on Mortality in the OMNI Trial. J Cardiovasc Electrophysiol 2016;27:192-9. [PMID: 26501695 DOI: 10.1111/jce.12860] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
60 Bitter T, Gutleben K, Nölker G, Dimitriadis Z, Prinz C, Vogt J, Horstkotte D, Oldenburg O. Sleep-disordered breathing and inappropriate defibrillator shocks in chronic heart failure. Herzschr Elektrophys 2014;25:198-205. [DOI: 10.1007/s00399-014-0324-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
61 Rowley CP, Gold MR. Subcutaneous Implantable Cardioverter Defibrillator. Circ: Arrhythmia and Electrophysiology 2012;5:587-93. [DOI: 10.1161/circep.111.964676] [Cited by in Crossref: 43] [Cited by in F6Publishing: 5] [Article Influence: 4.8] [Reference Citation Analysis]
62 Rhyner J, Knight BP. The Totally Subcutaneous Implantable Defibrillator. Cardiology Clinics 2014;32:225-37. [DOI: 10.1016/j.ccl.2013.12.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
63 Gupta A, Gholami P, Turakhia MP, Friday K, Heidenreich PA. Clinical reminders to providers of patients with reduced left ventricular ejection fraction increase defibrillator referral: a randomized trial. Circ Heart Fail 2014;7:140-5. [PMID: 24319096 DOI: 10.1161/CIRCHEARTFAILURE.113.000753] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
64 Stewart GC, Weintraub JR, Pratibhu PP, Semigran MJ, Camuso JM, Brooks K, Tsang SW, Anello MS, Nguyen VT, Lewis EF, Nohria A, Desai AS, Givertz MM, Stevenson LW. Patient expectations from implantable defibrillators to prevent death in heart failure. J Card Fail 2010;16:106-13. [PMID: 20142021 DOI: 10.1016/j.cardfail.2009.09.003] [Cited by in Crossref: 91] [Cited by in F6Publishing: 64] [Article Influence: 7.6] [Reference Citation Analysis]
65 Banna M, Indik JH. Risk Stratification and Prevention of Sudden Death in Patients with Heart Failure. Curr Treat Options Cardio Med 2011;13:517-27. [DOI: 10.1007/s11936-011-0144-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
66 Mishkin JD, Saxonhouse SJ, Woo GW, Burkart TA, Miles WM, Conti JB, Schofield RS, Sears SF, Aranda JM. Appropriate Evaluation and Treatment of Heart Failure Patients After Implantable Cardioverter-Defibrillator Discharge. Journal of the American College of Cardiology 2009;54:1993-2000. [DOI: 10.1016/j.jacc.2009.07.039] [Cited by in Crossref: 51] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
67 Beggs SAS, Jhund PS, Jackson CE, McMurray JJV, Gardner RS. Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: a review and meta-analysis. Heart 2018;104:144-50. [PMID: 28986406 DOI: 10.1136/heartjnl-2016-310850] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
68 Brignole M. Are complications of implantable defibrillators under-estimated and benefits over-estimated? Europace 2009;11:1129-33. [DOI: 10.1093/europace/eup174] [Cited by in Crossref: 52] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
69 Cevik C, Perez-verdia A, Nugent K. Implantable cardioverter defibrillators and their role in heart failure progression. Europace 2009;11:710-5. [DOI: 10.1093/europace/eup091] [Cited by in Crossref: 34] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
70 Brojmohun A, Lou JY, Zardkoohi O, Funk MC. Protected from Torsades de Pointes? What Psychiatrists Need to Know About Pacemakers and Defibrillators. Psychosomatics 2013;54:407-17. [DOI: 10.1016/j.psym.2013.02.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
71 Yoruk A, Sherazi S, Massey HT, Kutyifa V, McNitt S, Hallinan W, Huang DT, Chen L, Aktas MK. Predictors and clinical relevance of ventricular tachyarrhythmias in ambulatory patients with a continuous flow left ventricular assist device. Heart Rhythm 2016;13:1052-6. [PMID: 26829113 DOI: 10.1016/j.hrthm.2016.01.033] [Cited by in Crossref: 38] [Cited by in F6Publishing: 20] [Article Influence: 7.6] [Reference Citation Analysis]
72 Upadhyay GA, Singh JP. Cause of death and CRT device selection: striving for certitude? Eur Heart J 2015;36:2777-9. [DOI: 10.1093/eurheartj/ehv474] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
73 Scheurlen C, van den Bruck J, Wörmann J, Plenge T, Sultan A, Steven D, Lüker J. ICD therapy in the elderly: a retrospective single-center analysis of mortality. Herzschrittmacherther Elektrophysiol 2021;32:250-6. [PMID: 33512593 DOI: 10.1007/s00399-021-00742-x] [Reference Citation Analysis]
74 Brinker JA. Implantable cardioverter-defibrillator lead failure: how weak is the link? Nat Clin Pract Cardiovasc Med 2008;5:758-9. [PMID: 18838965 DOI: 10.1038/ncpcardio1367] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
75 Dadlani A, Dukes JW, Badhwar N. Inappropriate Implantable Cardioverter-Defibrillator Shock from QRS Double Counting in the Setting of Hyperkalemia. Cardiac Electrophysiology Clinics 2016;8:177-9. [DOI: 10.1016/j.ccep.2015.10.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
76 Garcia M, Miller VM, Gulati M, Hayes SN, Manson JE, Wenger NK, Bairey Merz CN, Mankad R, Pollak AW, Mieres J, Kling J, Mulvagh SL. Focused Cardiovascular Care for Women: The Need and Role in Clinical Practice. Mayo Clin Proc 2016;91:226-40. [PMID: 26848004 DOI: 10.1016/j.mayocp.2015.11.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 5.4] [Reference Citation Analysis]
77 Koneru JN, Swerdlow CD, Wood MA, Ellenbogen KA. Minimizing Inappropriate or “Unnecessary” Implantable Cardioverter-Defibrillator Shocks: Appropriate Programming. Circ Arrhythm Electrophysiol 2011;4:778-90. [DOI: 10.1161/circep.110.961243] [Cited by in Crossref: 45] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
78 Nielsen JC, Lin YJ, de Oliveira Figueiredo MJ, Sepehri Shamloo A, Alfie A, Boveda S, Dagres N, Di Toro D, Eckhardt LL, Ellenbogen K, Hardy C, Ikeda T, Jaswal A, Kaufman E, Krahn A, Kusano K, Kutyifa V, Lim HS, Lip GYH, Nava-Townsend S, Pak HN, Diez GR, Sauer W, Saxena A, Svendsen JH, Vanegas D, Vaseghi M, Wilde A, Bunch TJ, Buxton AE, Calvimontes G, Chao TF, Eckardt L, Estner H, Gillis AM, Isa R, Kautzner J, Maury P, Moss JD, Nam GB, Olshansky B, Pava Molano LF, Pimentel M, Prabhu M, Tzou WS, Sommer P, Swampillai J, Vidal A, Deneke T, Hindricks G, Leclercq C; ESC Scientific Document Group. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population. Heart Rhythm 2020;17:e269-316. [PMID: 32553607 DOI: 10.1016/j.hrthm.2020.05.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
79 Ruwald AC, Schuger C, Moss AJ, Kutyifa V, Olshansky B, Greenberg H, Cannom DS, Estes NA, Ruwald MH, Huang DT, Klein H, McNitt S, Beck CA, Goldstein R, Brown MW, Kautzner J, Shoda M, Wilber D, Zareba W, Daubert JP. Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT). Circ Arrhythm Electrophysiol 2014;7:785-92. [PMID: 25136077 DOI: 10.1161/CIRCEP.114.001623] [Cited by in Crossref: 88] [Cited by in F6Publishing: 13] [Article Influence: 12.6] [Reference Citation Analysis]
80 Robbers LFHJ, Delewi R, Nijveldt R, Hirsch A, Beek AM, Kemme MJB, van Beurden Y, van der Laan AM, van der Vleuten PA, Tio RA, Zijlstra F, Piek JJ, van Rossum AC. Myocardial infarct heterogeneity assessment by late gadolinium enhancement cardiovascular magnetic resonance imaging shows predictive value for ventricular arrhythmia development after acute myocardial infarction. European Heart Journal - Cardiovascular Imaging 2013;14:1150-8. [DOI: 10.1093/ehjci/jet111] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
81 Raitt MH. Inappropriate Implantable Defibrillator Shocks. Journal of the American College of Cardiology 2013;62:1351-2. [DOI: 10.1016/j.jacc.2013.05.055] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
82 Habibović M, Pedersen SS, van den Broek KC, Theuns DA, Jordaens L, van der Voort PH, Alings M, Denollet J. Anxiety and risk of ventricular arrhythmias or mortality in patients with an implantable cardioverter defibrillator. Psychosom Med 2013;75:36-41. [PMID: 23197843 DOI: 10.1097/PSY.0b013e3182769426] [Cited by in Crossref: 33] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
83 Magnusson P, Gadler F, Liv P, Mörner S. Hypertrophic Cardiomyopathy and Implantable Defibrillators in Sweden: Inappropriate Shocks and Complications Requiring Surgery: Inappropriate ICD Shocks and Complications in HCM. J Cardiovasc Electrophysiol 2015;26:1088-94. [DOI: 10.1111/jce.12750] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
84 Sham'a RA, Nery P, Sadek M, Yung D, Redpath C, Perrin M, Sarak B, Birnie D. Myocardial injury secondary to ICD shocks: insights from patients with lead fracture. Pacing Clin Electrophysiol 2014;37:237-41. [PMID: 23998856 DOI: 10.1111/pace.12263] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
85 Klein HU, Meltendorf U, Reek S, Smid J, Kuss S, Cygankiewicz I, Jons C, Szymkiewicz S, Buhtz F, Wollbrueck A. Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD). Pacing Clin Electrophysiol. 2010;33:353-367. [PMID: 19889186 DOI: 10.1111/j.1540-8159.2009.02590.x] [Cited by in Crossref: 102] [Cited by in F6Publishing: 55] [Article Influence: 8.5] [Reference Citation Analysis]
86 Ponti RD. Role of catheter ablation of ventricular tachycardia associated with structural heart disease. World J Cardiol 2011;3:339-50. [PMID: 22125669 DOI: 10.4330/wjc.v3.i11.339] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
87 Verschure DO, de Groot JR, Mirzaei S, Gheysens O, Nakajima K, van Eck-Smit BLF, Aernout Somsen G, Verberne HJ. Cardiac 123I-mIBG scintigraphy is associated with freedom of appropriate ICD therapy in stable chronic heart failure patients. Int J Cardiol 2017;248:403-8. [PMID: 28847545 DOI: 10.1016/j.ijcard.2017.08.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
88 Yung D, Birnie D, Dorian P, Healey JS, Simpson CS, Crystal E, Krahn AD, Khaykin Y, Cameron D, Chen Z, Lee DS. Survival after implantable cardioverter-defibrillator implantation in the elderly. Circulation 2013;127:2383-92. [PMID: 23775193 DOI: 10.1161/CIRCULATIONAHA.113.001442] [Cited by in Crossref: 71] [Cited by in F6Publishing: 12] [Article Influence: 8.9] [Reference Citation Analysis]
89 Maytin M, Love CJ, Fischer A, Carrillo RG, Garisto JD, Bongiorni MG, Segreti L, John RM, Michaud GF, Albert CM, Epstein LM. Multicenter Experience With Extraction of the Sprint Fidelis Implantable Cardioverter-Defibrillator Lead. Journal of the American College of Cardiology 2010;56:646-50. [DOI: 10.1016/j.jacc.2010.03.058] [Cited by in Crossref: 76] [Cited by in F6Publishing: 49] [Article Influence: 6.9] [Reference Citation Analysis]
90 Chen J, Johnson G, Hellkamp AS, Anderson J, Mark DB, Lee KL, Bardy GH, Poole JE. Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). J Am Coll Cardiol 2013;61:2161-8. [PMID: 23541974 DOI: 10.1016/j.jacc.2013.02.046] [Cited by in Crossref: 44] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
91 Wazni O, Wilkoff BL. Strategic choices to reduce implantable cardioverter-defibrillator-related morbidity. Nat Rev Cardiol 2010;7:376-83. [DOI: 10.1038/nrcardio.2010.50] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
92 Chen Z, Kotecha T, Crichton S, Shetty A, Sohal M, Arujuna A, Kirubakaran S, Bostock J, Cooklin M, O'Neill M, Wright M, Gill JS, Rinaldi CA. Lower incidence of inappropriate shock therapy in patients with combined cardiac resynchronisation therapy defibrillators (CRT-D) compared with patients with non-CRT defibrillators (ICDs). Int J Clin Pract 2013;67:733-9. [PMID: 23869676 DOI: 10.1111/ijcp.12033] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
93 Marcus GM, Chan DW, Redberg RF. Recollection of pain due to inappropriate versus appropriate implantable cardioverter-defibrillator shocks. Pacing Clin Electrophysiol 2011;34:348-53. [PMID: 21077915 DOI: 10.1111/j.1540-8159.2010.02971.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
94 Nishii N, Noda T, Nitta T, Aizawa Y, Ohe T, Kurita T. Risk factors for the first and second inappropriate implantable cardioverter-defibrillator therapy. Int J Cardiol Heart Vasc 2021;34:100779. [PMID: 33997254 DOI: 10.1016/j.ijcha.2021.100779] [Reference Citation Analysis]
95 Maurizi N, Olivotto I, Olde Nordkamp LR, Baldini K, Fumagalli C, Brouwer TF, Knops RE, Cecchi F. Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy. Heart Rhythm 2016;13:457-63. [DOI: 10.1016/j.hrthm.2015.09.007] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
96 Aktaş MK, Younis A, Zareba W, Kutyifa V, Klein H, Daubert JP, Estes M, McNitt S, Polonsky B, Goldenberg I. Survival After Implantable Cardioverter-Defibrillator Shocks. J Am Coll Cardiol 2021;77:2453-62. [PMID: 34016257 DOI: 10.1016/j.jacc.2021.03.329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Pedersen SS, Tekle FB, Hoogwegt MT, Jordaens L, Theuns DA. Shock and patient preimplantation type D personality are associated with poor health status in patients with implantable cardioverter-defibrillator. Circ Cardiovasc Qual Outcomes 2012;5:373-80. [PMID: 22570357 DOI: 10.1161/CIRCOUTCOMES.111.964197] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
98 Reinke F, Löher A, Köbe J, Eckardt L. Gegenwärtiger Stand und Probleme vollständig subkutaner ICD-Systeme (S-ICD®). Herzschr Elektrophys 2013;24:165-70. [DOI: 10.1007/s00399-013-0277-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
99 Arai S, Kawamura M, Gokan T, Yoshikawa K, Ogawa K, Ochi A, Munetsugu Y, Ito H, Shinke T. Relationship between device-detected subclinical atrial fibrillation and heart failure in patients with cardiac resynchronization therapy defibrillator. Clin Cardiol 2020;43:1517-23. [PMID: 32989791 DOI: 10.1002/clc.23471] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
100 Goldberger JJ, Passman R, Arora R, Kadish AH. A Higher than Expected Prevalence of AV Nodal Reentrant Tachycardia in Patients Receiving Implantable Cardioverter-Defibrillators: AVNRT IN PATIENTS WITH ICDS. Pacing and Clinical Electrophysiology 2011;34:584-6. [DOI: 10.1111/j.1540-8159.2010.03012.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
101 Swerdlow CD, Asirvatham SJ, Ellenbogen KA, Friedman PA. Troubleshooting implanted cardioverter defibrillator sensing problems I. Circ Arrhythm Electrophysiol 2014;7:1237-61. [PMID: 25516582 DOI: 10.1161/CIRCEP.114.002344] [Cited by in Crossref: 52] [Cited by in F6Publishing: 5] [Article Influence: 8.7] [Reference Citation Analysis]
102 Horlbeck FW, Schwab JO. Programming implantable cardioverter/defibrillators and outcomes. F1000Prime Rep 2015;7:10. [PMID: 25705393 DOI: 10.12703/P7-10] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
103 Li X, Yang D, Kusumoto F, Shen W, Mulpuru S, Zhou S, Liang J, Wu G, Yang M, Liu J, Friedman PA, Cha Y. Predictors and outcomes of cardiac resynchronization therapy extended to the second generator. Heart Rhythm 2017;14:1793-800. [DOI: 10.1016/j.hrthm.2017.09.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
104 Lo R, Al-Ahmad A, Hsia H, Zei PC, Wang PJ. Optimal Programming of ICDs for Prevention of Appropriate and Inappropriate Shocks. Curr Treat Options Cardiovasc Med 2008;10:408-16. [PMID: 18814830 DOI: 10.1007/s11936-008-0032-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
105 Ananwattanasuk T, Tanawuttiwat T, Chokesuwattanaskul R, Lathkar-pradhan S, Barham W, Oral H, Thakur RK, Jongnarangsin K. Programming implantable cardioverter–defibrillator in primary prevention: Guideline concordance and outcomes. Heart Rhythm 2020;17:1101-6. [DOI: 10.1016/j.hrthm.2020.02.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
106 Braunschweig F, Boriani G, Bauer A, Hatala R, Herrmann-lingen C, Kautzner J, Pedersen SS, Pehrson S, Ricci R, Schalij MJ. Management of patients receiving implantable cardiac defibrillator shocks: Recommendations for acute and long-term patient management. Europace 2010;12:1673-90. [DOI: 10.1093/europace/euq316] [Cited by in Crossref: 74] [Cited by in F6Publishing: 44] [Article Influence: 6.7] [Reference Citation Analysis]
107 Buber J, Luria D, Gurevitz O, Bar-lev D, Eldar M, Glikson M. Safety and efficacy of strategic implantable cardioverter-defibrillator programming to reduce the shock delivery burden in a primary prevention patient population. Europace 2014;16:227-34. [DOI: 10.1093/europace/eut302] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
108 Rickard J, Wilkoff BL. Advances in implantable cardioverter defibrillator therapy. Expert Rev Cardiovasc Ther 2016;14:291-9. [PMID: 26653411 DOI: 10.1586/14779072.2016.1131124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
109 Shepard RK, Ellenbogen KA. Predicting Outcome After Implantable Cardioverter-Defibrillator Therapy. Journal of the American College of Cardiology 2009;54:829-31. [DOI: 10.1016/j.jacc.2009.06.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
110 Liew R. Inappropriate defibrillator shocks and mortality. Heart 2013;99:1223-4. [DOI: 10.1136/heartjnl-2013-304031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
111 Sengupta J, Abdelhadi R. Approach to reduction of ventricular arrhythmias and implantable cardioverter-defibrillator therapies in patients with heart failure. Current Opinion in Cardiology 2013;28:337-43. [DOI: 10.1097/hco.0b013e3283604420] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
112 Morris PB, Ference BA, Jahangir E, Feldman DN, Ryan JJ, Bahrami H, El-Chami MF, Bhakta S, Winchester DE, Al-Mallah MH, Sanchez Shields M, Deedwania P, Mehta LS, Phan BA, Benowitz NL. Cardiovascular Effects of Exposure to Cigarette Smoke and Electronic Cigarettes: Clinical Perspectives From the Prevention of Cardiovascular Disease Section Leadership Council and Early Career Councils of the American College of Cardiology. J Am Coll Cardiol 2015;66:1378-91. [PMID: 26383726 DOI: 10.1016/j.jacc.2015.07.037] [Cited by in Crossref: 103] [Cited by in F6Publishing: 77] [Article Influence: 20.6] [Reference Citation Analysis]
113 Gorenek B, Blomström Lundqvist C, Brugada Terradellas J, Camm AJ, Hindricks G, Huber K, Kirchhof P, Kuck K, Kudaiberdieva G, Lin T, Raviele A, Santini M, Tilz RR, Valgimigli M, Vos MA, Vrints C, Zeymer U, Kristiansen SB, Lip GY, Potpara T, Fauchier L, Sticherling C, Roffi M, Widimsky P, Mehilli J, Lettino M, Schiele F, Sinnaeve P, Boriani G, Lane D, Savelieva I; ESC Scientific Document Group. Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. EP Europace 2014;16:1655-73. [DOI: 10.1093/europace/euu208] [Cited by in Crossref: 74] [Cited by in F6Publishing: 37] [Article Influence: 10.6] [Reference Citation Analysis]
114 Chung MK. The Role of the Wearable Cardioverter Defibrillator in Clinical Practice. Cardiology Clinics 2014;32:253-70. [DOI: 10.1016/j.ccl.2013.11.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
115 Keil L, Chevalier C, Kirchhof P, Blankenberg S, Lund G, Müllerleile K, Magnussen C. CMR-Based Risk Stratification of Sudden Cardiac Death and Use of Implantable Cardioverter-Defibrillator in Non-Ischemic Cardiomyopathy. Int J Mol Sci 2021;22:7115. [PMID: 34281168 DOI: 10.3390/ijms22137115] [Reference Citation Analysis]
116 Stempniewicz P, Cheng A, Connolly A, Wang XY, Calkins H, Tomaselli GF, Berger RD, Tereshchenko LG. Appropriate and inappropriate electrical therapies delivered by an implantable cardioverter-defibrillator: effect on intracardiac electrogram. J Cardiovasc Electrophysiol 2011;22:554-60. [PMID: 21087331 DOI: 10.1111/j.1540-8167.2010.01958.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
117 Dillon KA, Szymkiewicz SJ, Kaib TE. Evaluation of the effectiveness of a wearable cardioverter defibrillator detection algorithm. J Electrocardiol 2010;43:63-7. [PMID: 19570548 DOI: 10.1016/j.jelectrocard.2009.05.010] [Cited by in Crossref: 31] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
118 Aziz S, Leon AR, El-chami MF. The Subcutaneous Defibrillator. Journal of the American College of Cardiology 2014;63:1473-9. [DOI: 10.1016/j.jacc.2014.01.018] [Cited by in Crossref: 61] [Cited by in F6Publishing: 24] [Article Influence: 8.7] [Reference Citation Analysis]
119 van der Heijden AC, Borleffs CJ, Buiten MS, Thijssen J, van Rees JB, Cannegieter SC, Schalij MJ, van Erven L. The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complications. Heart Rhythm. 2015;12:1169-1176. [PMID: 25749138 DOI: 10.1016/j.hrthm.2015.02.035] [Cited by in Crossref: 57] [Cited by in F6Publishing: 35] [Article Influence: 9.5] [Reference Citation Analysis]
120 Schaer BA, Koller MT, Sticherling C, Altmann D, Joerg L, Osswald S. Longevity of implantable cardioverter-defibrillators, influencing factors, and comparison to industry-projected longevity. Heart Rhythm 2009;6:1737-43. [DOI: 10.1016/j.hrthm.2009.09.013] [Cited by in Crossref: 49] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
121 Sweeney MO. The Implantable Cardioverter-Defibrillator Minimalist: An Approach to Patient Follow-Up and Management of Implantable Defibrillators. Circulation 2012;126:369-77. [DOI: 10.1161/circulationaha.111.023887] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
122 Lewis KB, Stacey D, Matlock DD. Making Decisions About Implantable Cardioverter-Defibrillators from Implantation to End of Life: An Integrative Review of Patients’ Perspectives. Patient 2014;7:243-60. [DOI: 10.1007/s40271-014-0055-2] [Cited by in Crossref: 52] [Cited by in F6Publishing: 32] [Article Influence: 7.4] [Reference Citation Analysis]
123 Upadhyay GA, Steinberg JS. Managing atrial fibrillation in the CRT patient: Controversy or consensus? Heart Rhythm 2012;9:S51-9. [DOI: 10.1016/j.hrthm.2012.04.030] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
124 Hamo CE, Gheorghiade M, Butler J. Novel Endpoints for Heart Failure Clinical Trials. Curr Heart Fail Rep 2017;14:210-6. [DOI: 10.1007/s11897-017-0334-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
125 Bhavnani SP, Kluger J, Coleman CI, White CM, Guertin D, Shafi NA, Yarlagadda RK, Clyne CA. The prognostic impact of shocks for clinical and induced arrhythmias on morbidity and mortality among patients with implantable cardioverter-defibrillators. Heart Rhythm 2010;7:755-60. [DOI: 10.1016/j.hrthm.2010.02.039] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
126 Kolb C, Sturmer M, Sick P, Reif S, Davy JM, Molon G, Schwab JO, Mantovani G, Dan D, Lennerz C, Borri-brunetto A, Babuty D. Reduced Risk for Inappropriate Implantable Cardioverter-Defibrillator Shocks With Dual-Chamber Therapy Compared With Single-Chamber Therapy. JACC: Heart Failure 2014;2:611-9. [DOI: 10.1016/j.jchf.2014.05.015] [Cited by in Crossref: 34] [Cited by in F6Publishing: 21] [Article Influence: 4.9] [Reference Citation Analysis]
127 Kossaify A. Sensing and Detection Functions in Implantable Cardioverter Defibrillators: The Good, the Bad and the Ugly. Acta Cardiol Sin 2020;36:308-17. [PMID: 32675922 DOI: 10.6515/ACS.202007_36(4).20191201A] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
128 Werner RA. Cardiac innervation imaging as a risk stratification tool for potential device therapy candidates. J Nucl Cardiol 2020;27:1798-801. [PMID: 30357580 DOI: 10.1007/s12350-018-01475-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
129 Goldstein SA, LaPage MJ, Dechert BE, Serwer GA, Yu S, Lowery RE, Bradley DJ. Decreased inappropriate shocks with new generation ICDs in children and patients with congenital heart disease. Congenit Heart Dis 2018;13:413-8. [PMID: 29372620 DOI: 10.1111/chd.12585] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
130 Shah BK. Optimal Implantable Cardioverter Defibrillator Programming. Cardiol Rev 2017;25:30-5. [PMID: 27922468 DOI: 10.1097/CRD.0000000000000133] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
131 Sears SF, Matchett M, Conti JB. Effective management of ICD patient psychosocial issues and patient critical events. J Cardiovasc Electrophysiol 2009;20:1297-304. [PMID: 19563356 DOI: 10.1111/j.1540-8167.2009.01526.x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 36] [Article Influence: 5.4] [Reference Citation Analysis]
132 Hasan A, Sun B. Defibrillators and Cardiac Resynchronization Therapy as a Bridge to Cardiac Transplantation. Heart Failure Clinics 2011;7:227-39. [DOI: 10.1016/j.hfc.2011.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
133 Frey SM, Sticherling C, Bucher U, Widmer R, Ammann P, Kuhne M, Osswald S, Schaer B. Long-term performance of the Medtronic Sprint Fidelis lead: a matter of lead type? Europace 2012;14:1620-3. [DOI: 10.1093/europace/eus181] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
134 Jimenez-candil J, Hernandez J, Martin A, Ruiz-olgado M, Herrero J, Ledesma C, Morinigo J, Martin-luengo C. Influence of beta-blocker therapy on antitachycardia pacing effectiveness for monomorphic ventricular tachycardias occurring in implantable cardioverter-defibrillator patients: a dose-dependent effect. Europace 2010;12:1231-8. [DOI: 10.1093/europace/euq164] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
135 D’souza BA, Epstein AE, Garcia FC, Kim YY, Agarwal SC, Belott PH, Burke MC, Leon AR, Morgan JM, Patton KK, Shah M. Outcomes in Patients With Congenital Heart Disease Receiving the Subcutaneous Implantable-Cardioverter Defibrillator. JACC: Clinical Electrophysiology 2016;2:615-22. [DOI: 10.1016/j.jacep.2016.02.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
136 Liew R. Electrocardiogram-based predictors of sudden cardiac death in patients with coronary artery disease. Clin Cardiol 2011;34:466-73. [PMID: 21717472 DOI: 10.1002/clc.20924] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
137 Elayi CS, Whitbeck MG, Charnigo R, Shah J, Macaulay TE, Morales G, Gurley JC, Kakavand B, Thal S, Ching CK. Is there an association between external cardioversions and long-term mortality and morbidity? Insights from the Atrial Fibrillation Follow-up Investigation of Rhythm Management study. Circ Arrhythm Electrophysiol. 2011;4:465-469. [PMID: 21511994 DOI: 10.1161/circep.110.960591] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
138 Auricchio A, Meijer A, Kurita T, Schloss E, Brinkman K, Claessens-van Ooijen M, Sterns L. Safety, efficacy, and performance of new discrimination algorithms to reduce inappropriate and unnecessary shocks: the PainFree SST clinical study design. Europace 2011;13:1484-93. [DOI: 10.1093/europace/eur133] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
139 Rossi P, Bianchi S, Monari G, Della Scala A, Porcelli D, Valsecchi S, Canonaco S, Kornet L, Azzolini P. Vagal tone augmentation to the atrioventricular node in humans: Efficacy and safety of burst endocardial stimulation. Heart Rhythm 2010;7:683-9. [DOI: 10.1016/j.hrthm.2010.01.029] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
140 Poole JE, Gold MR. Who Should Receive the Subcutaneous Implanted Defibrillator?: The Subcutaneous Implantable Cardioverter Defibrillator (ICD) Should Be Considered in all ICD Patients Who Do Not Require Pacing. Circ: Arrhythmia and Electrophysiology 2013;6:1236-45. [DOI: 10.1161/circep.113.000481] [Cited by in Crossref: 31] [Cited by in F6Publishing: 4] [Article Influence: 3.9] [Reference Citation Analysis]
141 Vegh EM, Sood N, Singh JP. The Role of Ablation of the Atrioventricular Junction in Patients with Heart Failure and Atrial Fibrillation. Heart Failure Clinics 2013;9:489-99. [DOI: 10.1016/j.hfc.2013.07.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
142 Li A, Kaura A, Sunderland N, Dhillon PS, Scott PA. The Significance of Shocks in Implantable Cardioverter Defibrillator Recipients. Arrhythm Electrophysiol Rev 2016;5:110-6. [PMID: 27617089 DOI: 10.15420/AER.2016.12.2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 2.4] [Reference Citation Analysis]
143 Boveda S, Narayanan K, Jacob S, Providencia R, Algalarrondo V, Bouzeman A, Beganton F, Defaye P, Perier M, Sadoul N, Piot O, Klug D, Gras D, Fauchier L, Bordachar P, Babuty D, Deharo J, Leclercq C, Marijon E; on Behalf of the DAI-PP Investigators. Temporal Trends Over a Decade of Defibrillator Therapy for Primary Prevention in Community Practice: Temporal Trends Over a Decade of Defibrillator Therapy. J Cardiovasc Electrophysiol 2017;28:666-73. [DOI: 10.1111/jce.13198] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
144 Goldberger JJ, Passman R. Implantable Cardioverter-Defibrillator Therapy After Acute Myocardial Infarction. Journal of the American College of Cardiology 2009;54:2001-5. [DOI: 10.1016/j.jacc.2009.08.018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
145 Nishii N, Miyoshi A, Kubo M, Miyamoto M, Morimoto Y, Kawada S, Nakagawa K, Watanabe A, Nakamura K, Morita H, Ito H. Analysis of arrhythmic events is useful to detect lead failure earlier in patients followed by remote monitoring. J Cardiovasc Electrophysiol 2018;29:463-70. [DOI: 10.1111/jce.13399] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
146 De Vincentis G, Frantellizzi V, Fedele F, Farcomeni A, Scarparo P, Salvi N, Fegatelli DA, Mancone M, Verschure DO, Verberne HJ. Role of cardiac 123I-mIBG imaging in predicting arrhythmic events in stable chronic heart failure patients with an ICD. J Nucl Cardiol 2019;26:1188-96. [PMID: 29594915 DOI: 10.1007/s12350-018-1258-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 7.7] [Reference Citation Analysis]
147 Sung RK, Massie BM, Varosy PD, Moore H, Rumsfeld J, Lee BK, Keung E. Long-term electrical survival analysis of Riata and Riata ST silicone leads: National Veterans Affairs experience. Heart Rhythm 2012;9:1954-61. [DOI: 10.1016/j.hrthm.2012.08.006] [Cited by in Crossref: 55] [Cited by in F6Publishing: 38] [Article Influence: 6.1] [Reference Citation Analysis]
148 Chery G, Kamp N, Kosinski AS, Schmidler GS, Lopes RD, Patel M, Al-Khatib SM. Prognostic value of myocardial fibrosis on cardiac magnetic resonance imaging in patients with ischemic cardiomyopathy: A systematic review. Am Heart J 2020;229:52-60. [PMID: 32916608 DOI: 10.1016/j.ahj.2020.08.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
149 Karnik AA, Helm RH, Monahan KM. Mechanisms and management of inappropriate therapy in subcutaneous implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 2018;30:402-9. [DOI: 10.1111/jce.13831] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
150 Turnage TA, Kpaeyeh Jr JA, Gold MR. The Subcutaneous Implantable Cardioverter-Defibrillator: New Insights and Expanding Populations. US Cardiology Review 2018;12:66-70. [DOI: 10.15420/usc.2017:37:1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
151 Kutyifa V, Daubert JP, Schuger C, Goldenberg I, Klein H, Aktas MK, Mcnitt S, Stockburger M, Merkely B, Zareba W, Moss AJ. Novel ICD Programming and Inappropriate ICD Therapy in CRT-D Versus ICD Patients: A MADIT-RIT Sub-Study. Circ: Arrhythmia and Electrophysiology 2016;9. [DOI: 10.1161/circep.114.001965] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
152 Kosiuk J, Nedios S, Darma A, Rolf S, Richter S, Arya A, Piorkowski C, Gaspar T, Sommer P, Husser D, Hindricks G, Bollmann A. Impact of single atrial fibrillation catheter ablation on implantable cardioverter defibrillator therapies in patients with ischaemic and non-ischaemic cardiomyopathies. Europace 2014;16:1322-6. [DOI: 10.1093/europace/euu018] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
153 Thomas IC, Cork DP, Levy A, Nayak H, Beshai JF, Burke MC, Moss JD. ICD Lead Parameters, Performance, and Adverse Events following Continuous-Flow LVAD Implantation: ICD PERFORMANCE POST-LVAD. Pacing and Clinical Electrophysiology 2014;37:464-72. [DOI: 10.1111/pace.12290] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
154 Dichtl W, Wolber T, Paoli U, Brüllmann S, Stühlinger M, Berger T, Spuller K, Strasak A, Pachinger O, Haegeli LM, Duru F, Hintringer F. Appropriate therapy but not inappropriate shocks predict survival in implantable cardioverter defibrillator patients. Clin Cardiol 2011;34:433-6. [PMID: 21678454 DOI: 10.1002/clc.20910] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
155 Raitt MH. Implantable cardioverter-defibrillator shocks: a double-edged sword? J Am Coll Cardiol 2008;51:1366-8. [PMID: 18387437 DOI: 10.1016/j.jacc.2007.12.032] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
156 Gwag HB, Lee SH, Kim JS, Park KM, On YK, Hwang GS, Park SW, Lee SH, Park SJ. Long-term evaluation of sensing variability of a floating atrial dipole in a single‑lead defibrillator: The mechanistic basis of long-term stability of amplified atrial electrogram. Int J Cardiol 2021;336:67-72. [PMID: 33992702 DOI: 10.1016/j.ijcard.2021.05.024] [Reference Citation Analysis]
157 Deneke T, Lawo T, Reinecke J, Buttler C, Grewe P, Shin D, Gerritse B, Mügge A, Lemke B, Kloppe A. Predictors of sustained ventricular arrhythmia episodes in patients with primary ICD indication: Male gender and AF in primary ICD prophylaxis. Herzschr Elektrophys 2011;22:219-25. [DOI: 10.1007/s00399-011-0152-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
158 Cutro R, Rich MW, Hauptman PJ. Device therapy in patients with heart failure and advanced age: too much too late? Int J Cardiol 2012;155:52-5. [PMID: 21342708 DOI: 10.1016/j.ijcard.2011.01.078] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
159 Tereshchenko LG, Faddis MN, Fetics BJ, Zelik KE, Efimov IR, Berger RD. Transient local injury current in right ventricular electrogram after implantable cardioverter-defibrillator shock predicts heart failure progression. J Am Coll Cardiol 2009;54:822-8. [PMID: 19695461 DOI: 10.1016/j.jacc.2009.06.004] [Cited by in Crossref: 51] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
160 Almehmadi F, Porta-Sánchez A, Ha ACT, Fischer HD, Wang X, Austin PC, Lee DS, Nanthakumar K. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry. J Am Heart Assoc 2017;6:e006220. [PMID: 28862957 DOI: 10.1161/JAHA.117.006220] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 3.8] [Reference Citation Analysis]
161 Mattsson G, Magnusson P. Long-term follow-up of implantable cardioverter defibrillator patients with regard to appropriate therapy, complications, and mortality. Pacing Clin Electrophysiol 2020;43:245-53. [PMID: 31891421 DOI: 10.1111/pace.13869] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
162 Pedersen SS, van den Broek KC, Erdman RAM, Jordaens L, Theuns DAMJ. Pre-implantation implantable cardioverter defibrillator concerns and Type D personality increase the risk of mortality in patients with an implantable cardioverter defibrillator. Europace 2010;12:1446-52. [DOI: 10.1093/europace/euq296] [Cited by in Crossref: 60] [Cited by in F6Publishing: 44] [Article Influence: 5.5] [Reference Citation Analysis]
163 Gasparini M, Menozzi C, Proclemer A, Landolina M, Iacopino S, Carboni A, Lombardo E, Regoli F, Biffi M, Burrone V, Denaro A, Boriani G. A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study. Eur Heart J 2009;30:2758-67. [PMID: 19567380 DOI: 10.1093/eurheartj/ehp247] [Cited by in Crossref: 119] [Cited by in F6Publishing: 69] [Article Influence: 9.9] [Reference Citation Analysis]
164 Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, Aguinaga L, Berger RD, Cuesta A, Daubert JP, Dubner S, Ellenbogen KA, Estes NA 3rd, Fenelon G, Garcia FC, Gasparini M, Haines DE, Healey JS, Hurtwitz JL, Keegan R, Kolb C, Kuck KH, Marinskis G, Martinelli M, McGuire M, Molina LG, Okumura K, Proclemer A, Russo AM, Singh JP, Swerdlow CD, Teo WS, Uribe W, Viskin S, Wang CC, Zhang S. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. J Arrhythm 2016;32:1-28. [PMID: 26949427 DOI: 10.1016/j.joa.2015.12.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 4.6] [Reference Citation Analysis]
165 Bitter T, Fox H, Gaddam S, Horstkotte D, Oldenburg O. Sleep-Disordered Breathing and Cardiac Arrhythmias. Can J Cardiol 2015;31:928-34. [PMID: 26037822 DOI: 10.1016/j.cjca.2015.04.022] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
166 Callum K, Graune C, Bowman E, Molden E, Leslie SJ. Remote monitoring of implantable defibrillators is associated with fewer inappropriate shocks and reduced time to medical assessment in a remote and rural area. World J Cardiol 2021;13:46-54. [PMID: 33791078 DOI: 10.4330/wjc.v13.i3.46] [Reference Citation Analysis]
167 Sweeney MO. Point: Implantable cardioverter-defibrillator shocks for ventricular tachyarrhythmias increase mortality. Heart Rhythm 2012;9:985-7. [DOI: 10.1016/j.hrthm.2011.11.035] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
168 Enriquez A, Ellenbogen KA, Boles U, Baranchuk A. Atrioventricular Nodal Reentrant Tachycardia in Implantable Cardioverter Defibrillators: Diagnosis and Troubleshooting: AVNRT in ICDs. J Cardiovasc Electrophysiol 2015;26:1282-8. [DOI: 10.1111/jce.12772] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
169 Mazurek JA, Jessup M. Understanding Heart Failure. Cardiac Electrophysiology Clinics 2015;7:557-75. [DOI: 10.1016/j.ccep.2015.08.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
170 Rowley CP, Lobodzinski SS, Gold MR. The Subcutaneous Defibrillator. Curr Treat Options Cardio Med 2012;14:550-7. [DOI: 10.1007/s11936-012-0196-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
171 Sweeney MO. The Contradiction of Appropriate Shocks in Primary Prevention ICDs: Increasing and Decreasing the Risk of Death. Circulation 2010;122:2638-41. [DOI: 10.1161/circulationaha.110.000208] [Cited by in Crossref: 29] [Cited by in F6Publishing: 4] [Article Influence: 2.6] [Reference Citation Analysis]
172 Ricci RP, Pignalberi C, Landolina M, Santini M, Lunati M, Boriani G, Proclemer A, Facchin D, Catanzariti D, Morani G, Gulizia M, Mangoni L, Grammatico A, Gasparini M; on behalf of the ClinicalService cardiological centres. Ventricular rate monitoring as a tool to predict and prevent atrial fibrillation-related inappropriate shocks in heart failure patients treated with cardiac resynchronisation therapy defibrillators. Heart 2014;100:848-54. [DOI: 10.1136/heartjnl-2013-305259] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
173 Seegers J, Vos MA, Flevari P, Willems R, Sohns C, Vollmann D, Lüthje L, Kremastinos DT, Floré V, Meine M, Tuinenburg A, Myles RC, Simon D, Brockmöller J, Friede T, Hasenfuß G, Lehnart SE, Zabel M; EUTrigTreat Clinical Study Investigators. Rationale, objectives, and design of the EUTrigTreat clinical study: a prospective observational study for arrhythmia risk stratification and assessment of interrelationships among repolarization markers and genotype. Europace 2012;14:416-22. [PMID: 22117037 DOI: 10.1093/europace/eur352] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
174 Bhavnani SP, Giedrimiene D, Coleman CI, Guertin D, Azeem M, Kluger J. The healthcare utilization and cost of treating patients experiencing inappropriate implantable cardioverter defibrillator shocks: a propensity score study. Pacing Clin Electrophysiol 2014;37:1315-23. [PMID: 25139346 DOI: 10.1111/pace.12465] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
175 Jiménez-candil J, Hernández J, Perdiguero P, Martín A, Moríñigo J, Bravo L, Durán O, Sánchez PL. Prognostic Significance of Nonsustained Ventricular Tachycardia Episodes Occurring Early After Implantable Cardioverter-Defibrillator Implantation Among Patients With Left Ventricular Dysfunction. The American Journal of Cardiology 2016;118:1503-10. [DOI: 10.1016/j.amjcard.2016.08.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
176 Martin DT, Hook BG, Chaudhry GM, Silver J. Multicenter Experience With Extraction of the Sprint Fidelis Implantable Cardioverter-Defibrillator Lead. Journal of the American College of Cardiology 2011;57:635-6. [DOI: 10.1016/j.jacc.2010.09.035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
177 Rosero SZ, Younis A, Jones P, McNitt S, Goldenberg I, Zareba W, Stein K, Kutyifa V. Utility of cardiovascular implantable electronic device-derived patient activity to predict clinical outcomes. Heart Rhythm 2021;18:1344-51. [PMID: 33887451 DOI: 10.1016/j.hrthm.2021.04.013] [Reference Citation Analysis]
178 Qian Z, Zhang Z, Guo J, Wang Y, Hou X, Feng G, Zou J. Association of Implantable Cardioverter Defibrillator Therapy with All-Cause Mortality-A Systematic Review and Meta-Analysis. Pacing Clin Electrophysiol 2016;39:81-8. [PMID: 26470761 DOI: 10.1111/pace.12766] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
179 Friehling M, Soman P. Newer applications of nuclear cardiology in systolic heart failure: detecting coronary artery disease and guiding device therapy. Curr Heart Fail Rep. 2011;8:106-112. [PMID: 21465127 DOI: 10.1007/s11897-011-0057-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
180 Vijgen J, Botto G, Camm J, Hoijer C, Jung W, Le Heuzey J, Lubinski A, Norekval TM, Santomauro M, Schalij M, Schmid J, Vardas P; Task force members. Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators. Europace 2009;11:1097-107. [DOI: 10.1093/europace/eup112] [Cited by in Crossref: 66] [Cited by in F6Publishing: 32] [Article Influence: 5.5] [Reference Citation Analysis]
181 Biton Y, Huang DT, Goldenberg I, Rosero S, Moss AJ, Kutyifa V, Mcnitt S, Strasberg B, Zareba W, Barsheshet A. Relationship between age and inappropriate implantable cardioverter-defibrillator therapy in MADIT-RIT (Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy). Heart Rhythm 2016;13:888-93. [DOI: 10.1016/j.hrthm.2015.12.032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
182 Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, Aguinaga L, Berger RD, Cuesta A, Daubert JP. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Heart Rhythm. 2016;13:e50-e86. [PMID: 26607062 DOI: 10.1016/j.hrthm.2015.11.018] [Cited by in Crossref: 136] [Cited by in F6Publishing: 68] [Article Influence: 22.7] [Reference Citation Analysis]
183 Kulkarni N, Link MS. Causes and Prevention of Inappropriate Implantable Cardioverter-Defibrillator Shocks. Card Electrophysiol Clin 2018;10:67-74. [PMID: 29428143 DOI: 10.1016/j.ccep.2017.11.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
184 Smith T, Theuns DA, Caliskan K, Jordaens L. Long-term follow-up of prophylactic implantable cardioverter-defibrillator-only therapy: comparison of ischemic and nonischemic heart disease. Clin Cardiol 2011;34:761-7. [PMID: 22038531 DOI: 10.1002/clc.20970] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
185 Deyell MW, Qi A, Chakrabarti S, Yeung-lai-wah JA, Tung S, Khoo C, Bennett MT, Qian H, Kerr CR. Prognostic impact of inappropriate defibrillator shocks in a population cohort. Heart 2013;99:1250-5. [DOI: 10.1136/heartjnl-2012-303407] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
186 Proclemer A, Muser D, Campana A, Zoni-Berisso M, Zecchin M, Locatelli A, Brieda M, Gramegna L, Santarone M, Chiodi L, Mazzone P, Rebellato L, Facchin D. Indication to cardioverter-defibrillator therapy and outcome in real world primary prevention. Data from the IRIDE [Italian registry of prophylactic implantation of defibrillators] study. Int J Cardiol 2013;168:1416-21. [PMID: 23287697 DOI: 10.1016/j.ijcard.2012.12.042] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
187 Witt CT, Kronborg MB, Nohr EA, Mortensen PT, Gerdes C, Jensen HK, Nielsen JC. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy. Europace 2016;18:413-9. [DOI: 10.1093/europace/euv212] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
188 Bianchi S, Rossi P, Schauerte P, Elvan A, Blomström-lundqvist C, Kornet L, Gal P, Mörtsell D, Wouters G, Gemein C. Increase of Ventricular Interval During Atrial Fibrillation by Atrioventricular Node Vagal Stimulation: Chronic Clinical Atrioventricular-Nodal Stimulation Download Study. Circ Arrhythm Electrophysiol 2015;8:562-8. [DOI: 10.1161/circep.114.002588] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
189 Stout KK, Broberg CS, Book WM, Cecchin F, Chen JM, Dimopoulos K, Everitt MD, Gatzoulis M, Harris L, Hsu DT, Kuvin JT, Law Y, Martin CM, Murphy AM, Ross HJ, Singh G, Spray TL. Chronic Heart Failure in Congenital Heart Disease: A Scientific Statement From the American Heart Association. Circulation 2016;133:770-801. [DOI: 10.1161/cir.0000000000000352] [Cited by in Crossref: 181] [Cited by in F6Publishing: 43] [Article Influence: 36.2] [Reference Citation Analysis]
190 Lampert R. Survival of Patients With Implantable Cardioverter Defibrillators in the Era of Remote-Monitoring: The 5000-Foot, High-Altitude View. Circulation 2010;122:2353-5. [DOI: 10.1161/circulationaha.110.991687] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
191 Looi KL, Gavin A, Cooper L, Dawson L, Slipper D, Lever N. Outcomes of patients with heart failure after primary prevention ICD unit generator replacement. Heart Asia 2019;11:e011162. [PMID: 31031836 DOI: 10.1136/heartasia-2018-011162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
192 Grace A. The subcutaneous implantable cardioverter-defibrillator. Curr Opin Cardiol 2014;29:10-9. [PMID: 24284982 DOI: 10.1097/HCO.0000000000000031] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
193 Malagù M, Ferri A, Mancuso O, Trevisan F, Nardozza M, Bertini M. Implantable cardioverter defibrillator management: an update. Future Cardiol 2016;12:673-88. [PMID: 27762625 DOI: 10.2217/fca-2016-0031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
194 Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, Aguinaga L, Berger RD, Cuesta A, Daubert JP, Dubner S, Ellenbogen KA, Estes NA 3rd, Fenelon G, Garcia FC, Gasparini M, Haines DE, Healey JS, Hurtwitz JL, Keegan R, Kolb C, Kuck KH, Marinskis G, Martinelli M, Mcguire M, Molina LG, Okumura K, Proclemer A, Russo AM, Singh JP, Swerdlow CD, Teo WS, Uribe W, Viskin S, Wang CC, Zhang S; Document Reviewers. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Europace 2016;18:159-83. [PMID: 26585598 DOI: 10.1093/europace/euv411] [Cited by in Crossref: 73] [Cited by in F6Publishing: 35] [Article Influence: 12.2] [Reference Citation Analysis]
195 Clementy N, Challal F, Marijon E, Boveda S, Defaye P, Leclercq C, Deharo JC, Sadoul N, Klug D, Piot O, Gras D, Bordachar P, Algalarrondo V, Fauchier L, Babuty D; DAI-PP Investigators. Very high rate programming in primary prevention patients with reduced ejection fraction implanted with a defibrillator: Results from a large multicenter controlled study. Heart Rhythm 2017;14:211-7. [PMID: 27989789 DOI: 10.1016/j.hrthm.2016.10.024] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
196 Caldwell J, Gula L, Ali FS, Miranda RI, Abdollah H, Baranchuk A, Michael K, Simpson C, Redfearn DP. Relative timing of near-field and far-field electrograms can determine the tachyarrhythmia site of origin. Heart Rhythm 2018;15:530-5. [DOI: 10.1016/j.hrthm.2017.12.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
197 Gard JJ, Friedman PA. Strategies to Reduce ICD Shocks: The Role of Supraventricular Tachycardia–Ventricular Tachycardia Discriminators. Cardiac Electrophysiology Clinics 2011;3:373-87. [DOI: 10.1016/j.ccep.2011.05.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
198 Pedersen SS, van den Broek KC. Implantable Cardioverter-Defibrillator Shocks and Their Adverse Impact on Patient-Centered Outcomes: Fact or Fiction? Journal of the American College of Cardiology 2008;52:1037-8. [DOI: 10.1016/j.jacc.2008.04.066] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
199 Kleemann T, Hochadel M, Strauss M, Skarlos A, Seidl K, Zahn R. Comparison Between Atrial Fibrillation-Triggered Implantable Cardioverter-Defibrillator (ICD) Shocks and Inappropriate Shocks Caused by Lead Failure: Different Impact on Prognosis in Clinical Practice. Journal of Cardiovascular Electrophysiology 2012;23:735-40. [DOI: 10.1111/j.1540-8167.2011.02279.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
200 Guédon-Moreau L, Kouakam C, Klug D, Marquié C, Brigadeau F, Boulé S, Blangy H, Lacroix D, Clémenty J, Sadoul N, Kacet S. Decreased delivery of inappropriate shocks achieved by remote monitoring of ICD: a substudy of the ECOST trial. J Cardiovasc Electrophysiol 2014;25:763-70. [PMID: 24602062 DOI: 10.1111/jce.12405] [Cited by in Crossref: 46] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
201 Driessen S, Napp A, Schmiedchen K, Kraus T, Stunder D. Electromagnetic interference in cardiac electronic implants caused by novel electrical appliances emitting electromagnetic fields in the intermediate frequency range: a systematic review. Europace 2019;21:219-29. [PMID: 29992289 DOI: 10.1093/europace/euy155] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 16.0] [Reference Citation Analysis]
202 Sears SF, Hauf JD, Kirian K, Hazelton G, Conti JB. Posttraumatic Stress and the Implantable Cardioverter-Defibrillator Patient: What the Electrophysiologist Needs to Know. Circ Arrhythm Electrophysiol 2011;4:242-50. [DOI: 10.1161/circep.110.957670] [Cited by in Crossref: 75] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
203 Brenyo A, Pietrasik G, Barsheshet A, Huang DT, Polonsky B, McNitt S, Moss AJ, Zareba W. QRS fragmentation and the risk of sudden cardiac death in MADIT II. J Cardiovasc Electrophysiol. 2012;23:1343-1348. [PMID: 22805297 DOI: 10.1111/j.1540-8167.2012.02390.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
204 Olde Nordkamp LR, Knops RE, Bardy GH, Blaauw Y, Boersma LV, Bos JS, Delnoy PPH, van Dessel PF, Driessen AH, de Groot JR, Herrman JPR, Jordaens LJ, Kooiman KM, Maass AH, Meine M, Mizusawa Y, Molhoek SG, van Opstal J, Tijssen JG, Wilde AA. Rationale and design of the PRAETORIAN trial: A Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy. American Heart Journal 2012;163:753-760.e2. [DOI: 10.1016/j.ahj.2012.02.012] [Cited by in Crossref: 126] [Cited by in F6Publishing: 74] [Article Influence: 14.0] [Reference Citation Analysis]
205 Dewidar O, Birnie D, Podinic I, Welch V, Wells GA. Sex differences in CRT device implantation rates, efficacy, and complications following implantation: protocol for a systematic review and meta-analysis of cohort studies. Syst Rev 2021;10:210. [PMID: 34301313 DOI: 10.1186/s13643-021-01746-x] [Reference Citation Analysis]
206 Kleemann T, Strauss M, Kouraki K, Zahn R. Clinical course and prognostic relevance of antitachycardia pacing-terminated ventricular tachyarrhythmias in implantable cardioverter-defibrillator patients. Europace 2015;17:1068-75. [PMID: 25687746 DOI: 10.1093/europace/euv007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
207 Powell BD, Saxon LA, Boehmer JP, Day JD, Gilliam FR 3rd, Heidenreich PA, Jones PW, Rousseau MJ, Hayes DL. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study. J Am Coll Cardiol. 2013;62:1674-1679. [PMID: 23810882 DOI: 10.1016/j.jacc.2013.04.083] [Cited by in Crossref: 100] [Cited by in F6Publishing: 60] [Article Influence: 12.5] [Reference Citation Analysis]
208 Bodin A, Labas V, Bisson A, Teixeira-Gomes AP, Blasco H, Tomas D, Combes-Soia L, Marcelo P, Miquelestorena-Standley E, Baron C, Angoulvant D, Babuty D, Clementy N. Acute pathophysiological myocardial changes following intra-cardiac electrical shocks using a proteomic approach in a sheep model. Sci Rep 2020;10:20252. [PMID: 33219330 DOI: 10.1038/s41598-020-77346-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
209 Santharam S, Hudsmith L, Thorne S, Clift P, Marshall H, De Bono J. Long-term follow-up of implantable cardioverter-defibrillators in adult congenital heart disease patients: indications and outcomes. Europace. [DOI: 10.1093/europace/euw076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
210 Biton Y, Baman JR, Polonsky B. Roles and indications for use of implantable defibrillator and resynchronization therapy in the prevention of sudden cardiac death in heart failure. Heart Fail Rev 2016;21:433-46. [DOI: 10.1007/s10741-016-9542-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
211 Crössmann A, Schulz SM, Kühlkamp V, Ritter O, Neuser H, Schumacher B, Bauer W, Pauli P. A Randomized Controlled Trial of Secondary Prevention of Anxiety and Distress in a German Sample of Patients With an Implantable Cardioverter Defibrillator. Psychosomatic Medicine 2010;72:434-41. [DOI: 10.1097/psy.0b013e3181d9bcec] [Cited by in Crossref: 37] [Cited by in F6Publishing: 9] [Article Influence: 3.4] [Reference Citation Analysis]
212 Auricchio A, Schloss EJ, Kurita T, Meijer A, Gerritse B, Zweibel S, Alsmadi FM, Leng CT, Sterns LD. Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results. Heart Rhythm 2015;12:926-36. [DOI: 10.1016/j.hrthm.2015.01.017] [Cited by in Crossref: 95] [Cited by in F6Publishing: 43] [Article Influence: 15.8] [Reference Citation Analysis]
213 Looi K, Tang A, Agarwal S. Ventricular arrhythmia storm in the era of implantable cardioverter-defibrillator. Postgrad Med J 2015;91:519-26. [DOI: 10.1136/postgradmedj-2015-133550] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
214 Tompkins CM, Mcnitt S, Polonsky B, Daubert JP, Wang PJ, Moss AJ, Zareba W, Kutyifa V. Sex Differences in Inappropriate ICD Device Therapies: MADIT-II and MADIT-CRT: Sex Differences in Inappropriate ICD Device Therapies. J Cardiovasc Electrophysiol 2017;28:94-102. [DOI: 10.1111/jce.13102] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
215 Bradfield J, Boyle NG. The paradox of ICD shocks: sudden cardiac death prevention--heart failure death acceleration. Heart Rhythm 2010;7:361-2. [PMID: 20185110 DOI: 10.1016/j.hrthm.2009.12.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
216 Saba S, Mclaughlin T, He M, Althouse A, Mulukutla S, Hernandez I. Cardiac resynchronization therapy using pacemakers vs defibrillators in patients with nonischemic cardiomyopathy: The United States experience from 2007 to 2014. Heart Rhythm 2019;16:1065-71. [DOI: 10.1016/j.hrthm.2019.04.028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
217 Borleffs CJW, van Rees JB, van Welsenes GH, van der Velde ET, van Erven L, Bax JJ, Schalij MJ. Prognostic Importance of Atrial Fibrillation in Implantable Cardioverter-Defibrillator Patients. Journal of the American College of Cardiology 2010;55:879-85. [DOI: 10.1016/j.jacc.2009.09.053] [Cited by in Crossref: 50] [Cited by in F6Publishing: 31] [Article Influence: 4.5] [Reference Citation Analysis]
218 Pianca N, Zaglia T, Mongillo M. Will cardiac optogenetics find the way through the obscure angles of heart physiology? Biochem Biophys Res Commun 2017;482:515-23. [PMID: 27871856 DOI: 10.1016/j.bbrc.2016.11.104] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
219 Aktas MK, Huang DT, Daubert JP, Schuger CD, McNitt S, Goldenberg I, Moss AJ, Zareba W. Effect of defibrillation threshold testing on heart failure hospitalization or death in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Heart Rhythm 2013;10:193-9. [PMID: 23085128 DOI: 10.1016/j.hrthm.2012.10.024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
220 Russo AM, Chung MK. Is Defibrillation Testing Necessary? Cardiology Clinics 2014;32:211-24. [DOI: 10.1016/j.ccl.2014.01.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
221 Masoudi FA, Go AS, Magid DJ, Cassidy-Bushrow AE, Doris JM, Fiocchi F, Garcia-Montilla R, Glenn KA, Goldberg RJ, Gupta N, Gurwitz JH, Hammill SC, Hayes JJ, Jackson N, Kadish A, Lauer M, Miller AW, Multerer D, Peterson PN, Reifler LM, Reynolds K, Saczynski JS, Schuger C, Sharma PP, Smith DH, Suits M, Sung SH, Varosy PD, Vidaillet HJ, Greenlee RT. Longitudinal study of implantable cardioverter-defibrillators: methods and clinical characteristics of patients receiving implantable cardioverter-defibrillators for primary prevention in contemporary practice. Circ Cardiovasc Qual Outcomes 2012;5:e78-85. [PMID: 23170006 DOI: 10.1161/CIRCOUTCOMES.112.965368] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
222 Russo AM, Chung MK. Is Defibrillation Testing Necessary for Implantable Transvenous Defibrillators?: Defibrillation Testing Is Necessary at the Time of Implantable Cardioverter Defibrillator Implantation. Circ: Arrhythmia and Electrophysiology 2014;7:337-46. [DOI: 10.1161/circep.113.000371] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
223 Olde Nordkamp LR, Brouwer TF, Barr C, Theuns DA, Boersma LV, Johansen JB, Neuzil P, Wilde AA, Carter N, Husby M, Lambiase PD, Knops RE. Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management. International Journal of Cardiology 2015;195:126-33. [DOI: 10.1016/j.ijcard.2015.05.135] [Cited by in Crossref: 95] [Cited by in F6Publishing: 53] [Article Influence: 15.8] [Reference Citation Analysis]
224 Boersma L, Barr C, Knops R, Theuns D, Eckardt L, Neuzil P, Scholten M, Hood M, Kuschyk J, Jones P, Duffy E, Husby M, Stein K, Lambiase PD. Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry. Journal of the American College of Cardiology 2017;70:830-41. [DOI: 10.1016/j.jacc.2017.06.040] [Cited by in Crossref: 167] [Cited by in F6Publishing: 92] [Article Influence: 41.8] [Reference Citation Analysis]
225 Banchs JE, Scher DL. Emerging role of digital technology and remote monitoring in the care of cardiac patients. Med Clin North Am 2015;99:877-96. [PMID: 26042888 DOI: 10.1016/j.mcna.2015.02.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
226 Nair GM, Nery PB, Redpath CJ, Birnie DH. Ventricular arrhythmias in patients with heart failure secondary to reduced ejection fraction: a current perspective. Curr Opin Cardiol 2014;29:152-9. [PMID: 24378634 DOI: 10.1097/HCO.0000000000000035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
227 Clementy N, Bodin A, Bisson A, Teixeira-Gomes AP, Roger S, Angoulvant D, Labas V, Babuty D. The Defibrillation Conundrum: New Insights into the Mechanisms of Shock-Related Myocardial Injury Sustained from a Life-Saving Therapy. Int J Mol Sci 2021;22:5003. [PMID: 34066832 DOI: 10.3390/ijms22095003] [Reference Citation Analysis]
228 Schuger C, Daubert JP, Brown MW, Cannom D, Estes NA 3rd, Hall WJ, Kayser T, Klein H, Olshansky B, Power KA, Wilber D, Zareba W, Moss AJ. Multicenter automatic defibrillator implantation trial: reduce inappropriate therapy (MADIT-RIT): background, rationale, and clinical protocol. Ann Noninvasive Electrocardiol 2012;17:176-85. [PMID: 22816536 DOI: 10.1111/j.1542-474X.2012.00531.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 1] [Article Influence: 3.6] [Reference Citation Analysis]
229 Gordon JS, Maynes EJ, O'Malley TJ, Pavri BB, Tchantchaleishvili V. Electromagnetic interference between implantable cardiac devices and continuous-flow left ventricular assist devices: a review. J Interv Card Electrophysiol 2021;61:1-10. [PMID: 33433742 DOI: 10.1007/s10840-020-00930-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
230 Kusayama T, Wan J, Doytchinova A, Wong J, Kabir RA, Mitscher G, Straka S, Shen C, Everett TH 4th, Chen PS. Skin sympathetic nerve activity and the temporal clustering of cardiac arrhythmias. JCI Insight 2019;4:125853. [PMID: 30811928 DOI: 10.1172/jci.insight.125853] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
231 Arenal Á, Hernández J, Calvo D, Ceballos C, Atéa L, Datino T, Atienza F, González-torrecilla E, Eídelman G, Miracle Á, Avila P, Bermejo J, Fernández-avilés F. Safety, Long-Term Results, and Predictors of Recurrence After Complete Endocardial Ventricular Tachycardia Substrate Ablation in Patients With Previous Myocardial Infarction. The American Journal of Cardiology 2013;111:499-505. [DOI: 10.1016/j.amjcard.2012.10.031] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
232 Volosin KJ, Exner DV, Wathen MS, Sherfesee L, Scinicariello AP, Gillberg JM. Combining Shock Reduction Strategies to Enhance ICD Therapy: A Role for Computer Modeling. Journal of Cardiovascular Electrophysiology 2011;22:280-9. [DOI: 10.1111/j.1540-8167.2010.01918.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
233 Miyazaki S, Taniguchi H, Kusa S, Komatsu Y, Ichihara N, Takagi T, Iwasawa J, Kuroi A, Nakamura H, Hachiya H, Hirao K, Iesaka Y. Catheter ablation of atrial tachyarrhythmias causing inappropriate implantable cardioverter-defibrillator shocks. Europace 2015;17:289-94. [PMID: 25061229 DOI: 10.1093/europace/euu185] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
234 Horlbeck FW, Mellert F, Kreuz J, Nickenig G, Schwab JO. Real-World Data on the Lifespan of Implantable Cardioverter-Defibrillators Depending on Manufacturers and the Amount of Ventricular Pacing. Journal of Cardiovascular Electrophysiology 2012;23:1336-42. [DOI: 10.1111/j.1540-8167.2012.02408.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
235 Zdarek J, Israel CW. Detection and discrimination of tachycardia in ICDs manufactured by St. Jude Medical. Herzschr Elektrophys 2016;27:226-39. [DOI: 10.1007/s00399-016-0455-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
236 Faulknier BA, Traub DM, Aktas MK, Aguila A, Rosero S, Daubert JP, Hall B, Shah A, Taylor S, Mcnitt S, Moss AJ, Zareba W, Huang DT. Time-Dependent Risk of Fidelis Lead Failure. The American Journal of Cardiology 2010;105:95-9. [DOI: 10.1016/j.amjcard.2009.08.655] [Cited by in Crossref: 38] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
237 Ben Morrison T, Jared Bunch T, Gersh BJ. Pathophysiology of concomitant atrial fibrillation and heart failure: implications for management. Nat Clin Pract Cardiovasc Med 2009;6:46-56. [PMID: 19047993 DOI: 10.1038/ncpcardio1414] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
238 Lopez EM, Malhotra R. Ventricular Tachycardia in Structural Heart Disease. J Innov Card Rhythm Manag 2019;10:3762-73. [PMID: 32477742 DOI: 10.19102/icrm.2019.100801] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
239 Gupta A, Hoang DD, Karliner L, Tice JA, Heidenreich P, Wang PJ, Turakhia MP. Ability of microvolt T-wave alternans to modify risk assessment of ventricular tachyarrhythmic events: a meta-analysis. Am Heart J. 2012;163:354-364. [PMID: 22424005 DOI: 10.1016/j.ahj.2011.11.021] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
240 Weinstock J, Madias C. The Subcutaneous Defibrillator. Cardiac Electrophysiology Clinics 2017;9:775-83. [DOI: 10.1016/j.ccep.2017.08.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
241 Atreya AR, Cook JR, Lindenauer PK. Complications arising from cardiac implantable electrophysiological devices: review of epidemiology, pathogenesis and prevention for the clinician. Postgraduate Medicine 2016;128:223-30. [DOI: 10.1080/00325481.2016.1151327] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
242 Pedersen SS, Van Den Broek KC, Van Den Berg M, Theuns DAMJ. Shock as a Determinant of Poor Patient-Centered Outcomes in Implantable Cardioverter Defibrillator Patients: Is There More to It Than Meets the Eye?: ICD SHOCK AND PATIENT-CENTERED OUTCOMES. Pacing and Clinical Electrophysiology 2010;33:1430-6. [DOI: 10.1111/j.1540-8159.2010.02845.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
243 Alvarez CK, Cronin E, Baker WL, Kluger J. Heart failure as a substrate and trigger for ventricular tachycardia. J Interv Card Electrophysiol. 2019;56:229-247. [PMID: 31598875 DOI: 10.1007/s10840-019-00623-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
244 van Dijk VF, Quast ABE, Schaap J, Balt JC, Kelder JC, Wijffels MCEF, de Groot JR, Boersma LVA. ICD implantation for secondary prevention in patients with ventricular arrhythmia in the setting of acute cardiac ischemia and a history of myocardial infarction. J Cardiovasc Electrophysiol 2020;31:536-43. [PMID: 31944462 DOI: 10.1111/jce.14357] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
245 Gold MR, Theuns DA, Knight BP, Sturdivant JL, Sanghera R, Ellenbogen KA, Wood MA, Burke MC. Head-To-Head Comparison of Arrhythmia Discrimination Performance of Subcutaneous and Transvenous ICD Arrhythmia Detection Algorithms: The START Study. Journal of Cardiovascular Electrophysiology 2012;23:359-66. [DOI: 10.1111/j.1540-8167.2011.02199.x] [Cited by in Crossref: 151] [Cited by in F6Publishing: 80] [Article Influence: 15.1] [Reference Citation Analysis]
246 von Kodolitsch Y, Bernhardt AM, Kölbel T, Detter C, Reichenspurner H, Debus ES, Schumacher U. Maximizing therapeutic success: The key concepts of individualized medical strategy (IMS). Cogent Medicine 2015;2:1109742. [DOI: 10.1080/2331205x.2015.1109742] [Cited by in Crossref: 11] [Article Influence: 1.8] [Reference Citation Analysis]
247 Larsen GK, Evans J, Lambert WE, Chen Y, Raitt MH. Shocks burden and increased mortality in implantable cardioverter-defibrillator patients. Heart Rhythm 2011;8:1881-6. [DOI: 10.1016/j.hrthm.2011.07.036] [Cited by in Crossref: 73] [Cited by in F6Publishing: 42] [Article Influence: 7.3] [Reference Citation Analysis]
248 Morrison TB, Friedman PA, Kallinen LM, Hodge DO, Crusan D, Kumar K, Hayes DL, Rea RF, Hauser RG. Impact of Implanted Recalled Sprint Fidelis Lead on Patient Mortality. Journal of the American College of Cardiology 2011;58:278-83. [DOI: 10.1016/j.jacc.2011.03.027] [Cited by in Crossref: 32] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
249 Crossley GH, Boyle A, Vitense H, Chang Y, Mead RH;  CONNECT Investigators. The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts. J Am Coll Cardiol. 2011;57:1181-1189. [PMID: 21255955 DOI: 10.1016/j.jacc.2010.12.012] [Cited by in Crossref: 343] [Cited by in F6Publishing: 198] [Article Influence: 34.3] [Reference Citation Analysis]
250 Chong D, Tan BY, Ho KL, Liew R, Teo WS, Ching CK. Clinical markers of organ dysfunction associated with increased 1-year mortality post-implantable cardioverter defibrillator implantation. EP Europace 2013;15:508-14. [DOI: 10.1093/europace/eus225] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
251 Yap S, Schaer BA, Bhagwandien RE, Kühne M, Dabiri Abkenari L, Osswald S, Szili-torok T, Sticherling C, Theuns DAMJ. Evaluation of the need of elective implantable cardioverter-defibrillator generator replacement in primary prevention patients without prior appropriate ICD therapy. Heart 2014;100:1188-92. [DOI: 10.1136/heartjnl-2014-305535] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
252 Wang S, Wu S, Xu L, Xiao F, Whinnett ZI, Vijayaraman P, Su L, Huang W. Feasibility and Efficacy of His Bundle Pacing or Left Bundle Pacing Combined With Atrioventricular Node Ablation in Patients With Persistent Atrial Fibrillation and Implantable Cardioverter-Defibrillator Therapy. J Am Heart Assoc 2019;8:e014253. [PMID: 31830874 DOI: 10.1161/JAHA.119.014253] [Cited by in Crossref: 27] [Cited by in F6Publishing: 10] [Article Influence: 13.5] [Reference Citation Analysis]
253 Ruwald AH, Sood N, Ruwald MH, Jons C, Clyne CA, Mcnitt S, Wang P, Zareba W, Moss AJ. Frequency of Inappropriate Therapy in Patients Implanted with Dual- Versus Single-Chamber ICD Devices in the ICD Arm of MADIT-CRT: Inappropriate Therapy in Single Versus Dual Chamber. J Cardiovasc Electrophysiol 2013;24:672-9. [DOI: 10.1111/jce.12099] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
254 Fox H, Bitter T, Horstkotte D, Oldenburg O. Sleep-Disordered Breathing and Arrhythmia in Heart Failure Patients. Sleep Med Clin 2017;12:229-41. [PMID: 28477777 DOI: 10.1016/j.jsmc.2017.01.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
255 Clementy N, Pierre B, Lallemand B, Marie O, Lemoine E, Cosnay P, Fauchier L, Babuty D. Long-term follow-up on high-rate cut-off programming for implantable cardioverter defibrillators in primary prevention patients with left ventricular systolic dysfunction. Europace 2012;14:968-74. [DOI: 10.1093/europace/eus028] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
256 Ruwald MH, Zareba W, Jons C, Zhang C, Ruwald AC, Olshansky B, McNitt S, Bloch Thomsen PE, Shoda M, Merkely B, Moss AJ, Kutyifa V. Influence of diabetes mellitus on inappropriate and appropriate implantable cardioverter-defibrillator therapy and mortality in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) Trial. Circulation 2013;128:694-701. [PMID: 23881862 DOI: 10.1161/CIRCULATIONAHA.113.002472] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 2.1] [Reference Citation Analysis]
257 Fischer A, Ousdigian KT, Johnson JW, Gillberg JM, Wilkoff BL. The impact of atrial fibrillation with rapid ventricular rates and device programming on shocks in 106,513 ICD and CRT-D patients. Heart Rhythm 2012;9:24-31. [DOI: 10.1016/j.hrthm.2011.08.005] [Cited by in Crossref: 41] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
258 Gao D, Van Herendael H, Alshengeiti L, Dorian P, Mangat I, Korley V, Ahmad K, Golovchiner G, Aves T, Pinter A. Mexiletine as an adjunctive therapy to amiodarone reduces the frequency of ventricular tachyarrhythmia events in patients with an implantable defibrillator. J Cardiovasc Pharmacol. 2013;62:199-204. [PMID: 23609328 DOI: 10.1097/fjc.0b013e31829651fe] [Cited by in Crossref: 39] [Cited by in F6Publishing: 3] [Article Influence: 5.6] [Reference Citation Analysis]
259 Naksuk N, Kunisaki KM, Benditt DG, Tholakanahalli V, Adabag S. Implantable Cardioverter-Defibrillators in Patients With COPD. Chest 2013;144:778-83. [DOI: 10.1378/chest.12-1883] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
260 Sood N, Al Badarin F, Parker M, Pullatt R, Jacobson AF, Bateman TM, Heller GV. Resting perfusion MPI-SPECT combined with cardiac 123I-mIBG sympathetic innervation imaging improves prediction of arrhythmic events in non-ischemic cardiomyopathy patients: sub-study from the ADMIRE-HF trial. J Nucl Cardiol. 2013;20:813-820. [PMID: 23864400 DOI: 10.1007/s12350-013-9750-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
261 Vest RN 3rd, Gold MR. Risk stratification of ventricular arrhythmias in patients with systolic heart failure. Curr Opin Cardiol 2010;25:268-75. [PMID: 20224387 DOI: 10.1097/HCO.0b013e3283387a73] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
262 Zarraga IGE, Dougherty CM, Macmurdy KS, Raitt MH. The Effect of Spironolactone on Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter-Defibrillators. Circ Arrhythm Electrophysiol 2012;5:739-47. [DOI: 10.1161/circep.112.970566] [Cited by in Crossref: 8] [Article Influence: 0.9] [Reference Citation Analysis]
263 Ruwald MH, Abu-zeitone A, Jons C, Ruwald A, Mcnitt S, Kutyifa V, Zareba W, Moss AJ. Impact of Carvedilol and Metoprolol on Inappropriate Implantable Cardioverter-Defibrillator Therapy. Journal of the American College of Cardiology 2013;62:1343-50. [DOI: 10.1016/j.jacc.2013.03.087] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
264 El-Battrawy I, Roterberg G, Liebe V, Ansari U, Lang S, Zhou X, Borggrefe M, Akin I. Implantable cardioverter-defibrillator in Brugada syndrome: Long-term follow-up. Clin Cardiol 2019;42:958-65. [PMID: 31441080 DOI: 10.1002/clc.23247] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
265 Schuger C, Daubert JP, Zareba W, Rosero S, Yong P, McNitt S, Kutyifa V. Reassessing the role of antitachycardia pacing in fast ventricular arrhythmias in primary prevention implantable cardioverter-defibrillator recipients: Results from MADIT-RIT. Heart Rhythm 2021;18:399-403. [PMID: 33232811 DOI: 10.1016/j.hrthm.2020.11.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
266 Bortnik M, Degiovanni A, Dell’era G, Cavallino C, Occhetta E, Marino P. Prevalence of ventricular arrhythmias in patients with cardiac resynchronization therapy without back-up ICD: a single-center experience. Journal of Cardiovascular Medicine 2014;15:301-6. [DOI: 10.2459/jcm.0b013e3283638148] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
267 Leenhardt A, Defaye P, Mouton E, Delay M, Delarche N, Dupuis J, Bizeau O, Mabo P, Cheggour S, Babuty D; on behalf of the OPERA Registry investigators. First inappropriate implantable cardioverter defibrillator therapy is often due to inaccurate device programming: analysis of the French OPERA registry. Europace 2012;14:1465-74. [DOI: 10.1093/europace/eus144] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
268 Gilliam FR, Hayes DL, Boehmer JP, Day J, Heidenreich PA, Seth M, Jones PW, Stein KM, Saxon LA. Real World Evaluation of Dual-Zone ICD and CRT-D Programming Compared to Single-Zone Programming: The ALTITUDE REDUCES Study. Journal of Cardiovascular Electrophysiology 2011;22:1023-9. [DOI: 10.1111/j.1540-8167.2011.02086.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
269 Guédon-Moreau L, Lacroix D, Sadoul N, Clémenty J, Kouakam C, Hermida JS, Aliot E, Boursier M, Bizeau O, Kacet S; ECOST trial Investigators. A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial. Eur Heart J 2013;34:605-14. [PMID: 23242192 DOI: 10.1093/eurheartj/ehs425] [Cited by in Crossref: 181] [Cited by in F6Publishing: 97] [Article Influence: 20.1] [Reference Citation Analysis]
270 Safak E, Eckardt L, Jung W, Ince H, Senges J, Hochadel M, Perings C, Spitzer S, Brachmann J, Seidl K, Hink HU, D'Ancona G. Determinants of inappropriate implantable cardioverter-defibrillator shocks: the German Device Registry perspective. J Interv Card Electrophysiol 2019;56:71-7. [PMID: 31375974 DOI: 10.1007/s10840-019-00600-4] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
271 Seegers J, Zabel M, Luthje L, Vollmann D. Ventricular oversensing due to manufacturer-related differences in implantable cardioverter-defibrillator signal processing and sensing lead properties. Europace 2010;12:1460-6. [DOI: 10.1093/europace/euq269] [Cited by in Crossref: 24] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
272 Kloppe A, Proclemer A, Arenal A, Lunati M, Martìnez Ferrer JB, Hersi A, Gulaj M, Wijffels MC, Santi E, Manotta L, Mangoni L, Gasparini M. Efficacy of Long Detection Interval Implantable Cardioverter-Defibrillator Settings in Secondary Prevention Population: Data From the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) Trial. Circulation 2014;130:308-14. [DOI: 10.1161/circulationaha.114.009468] [Cited by in Crossref: 57] [Cited by in F6Publishing: 13] [Article Influence: 8.1] [Reference Citation Analysis]
273 Wilton SB, Exner DV, Wyse DG, Yetisir E, Wells G, Tang AS, Healey JS. Frequency and Outcomes of Postrandomization Atrial Tachyarrhythmias in the Resynchronization/Defibrillation in Ambulatory Heart Failure Trial. Circ Arrhythm Electrophysiol 2016;9. [DOI: 10.1161/circep.115.003807] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
274 Swerdlow CD, Asirvatham SJ, Ellenbogen KA, Friedman PA. Troubleshooting implantable cardioverter-defibrillator sensing problems II. Circ Arrhythm Electrophysiol 2015;8:212-20. [PMID: 25691555 DOI: 10.1161/CIRCEP.114.002514] [Cited by in Crossref: 16] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
275 Al-khatib SM, Daubert JP, Anstrom KJ, Daoud EG, Gonzalez M, Saba S, Jackson KP, Reece T, Gu J, Pokorney SD, Granger CB, Hess PL, Mark DB, Stevenson WG. Catheter Ablation for Ventricular Tachycardia in Patients with an Implantable Cardioverter Defibrillator (CALYPSO) Pilot Trial: Catheter Ablation for Ventricular Tachycardia. J Cardiovasc Electrophysiol 2015;26:151-7. [DOI: 10.1111/jce.12567] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 5.9] [Reference Citation Analysis]
276 Niehues P, Frommeyer G, Reinke F, Eckardt L. [Subcutaneous implantable cardioverter-defibrillator : Current status and perspectives]. Herzschrittmacherther Elektrophysiol 2018;29:349-54. [PMID: 30306303 DOI: 10.1007/s00399-018-0593-8] [Reference Citation Analysis]
277 Denollet J, Tekle FB, Pedersen SS, van der Voort PH, Alings M, van den Broek KC. Prognostic importance of distressed (Type D) personality and shocks in patients with an implantable cardioverter defibrillator. International Journal of Cardiology 2013;167:2705-9. [DOI: 10.1016/j.ijcard.2012.06.114] [Cited by in Crossref: 35] [Cited by in F6Publishing: 12] [Article Influence: 4.4] [Reference Citation Analysis]
278 van Welsenes GH, van Rees JB, Borleffs CJW, Cannegieter SC, Bax JJ, van Erven L, Schalij MJ. Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients. Europace 2011;13:389-94. [DOI: 10.1093/europace/euq494] [Cited by in Crossref: 69] [Cited by in F6Publishing: 41] [Article Influence: 6.9] [Reference Citation Analysis]
279 Garnreiter JM, Pilcher TA, Etheridge SP, Saarel EV. Inappropriate ICD shocks in pediatrics and congenital heart disease patients: Risk factors and programming strategies. Heart Rhythm 2015;12:937-42. [DOI: 10.1016/j.hrthm.2015.01.028] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
280 Sedláček K, Ruwald A, Kutyifa V, Mcnitt S, Thomsen PEB, Klein H, Stockburger M, Wichterle D, Merkely B, De La Concha JF, Swissa M, Zareba W, Moss AJ, Kautzner J, Ruwald MH; for the MADIT-RIT Investigators. The Effect of ICD Programming on Inappropriate and Appropriate ICD Therapies in Ischemic and Nonischemic Cardiomyopathy: The MADIT-RIT Trial: ICD Programming in Ischemic and Nonischemic Cardiomyopathy. J Cardiovasc Electrophysiol 2015;26:424-33. [DOI: 10.1111/jce.12605] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
281 Nakajima K, Nakata T, Doi T, Tada H, Maruyama K. Machine learning-based risk model using 123I-metaiodobenzylguanidine to differentially predict modes of cardiac death in heart failure. J Nucl Cardiol 2020. [PMID: 32410060 DOI: 10.1007/s12350-020-02173-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
282 Parsi A, Byrne D, Glavin M, Jones E. Heart rate variability feature selection method for automated prediction of sudden cardiac death. Biomedical Signal Processing and Control 2021;65:102310. [DOI: 10.1016/j.bspc.2020.102310] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
283 Bax JJ, Di Carli M, Narula J, Delgado V. Multimodality imaging in ischaemic heart failure. Lancet 2019;393:1056-70. [PMID: 30860031 DOI: 10.1016/S0140-6736(18)33207-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 5.5] [Reference Citation Analysis]
284 Rajamani K, Goldberg AS, Wilkoff BL. Shock Avoidance and the Newer Tachycardia Therapy Algorithms. Cardiology Clinics 2014;32:191-200. [DOI: 10.1016/j.ccl.2014.01.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
285 Imberti JF, Vitolo M, Proietti M, Diemberger I, Ziacchi M, Biffi M, Boriani G. Driving restriction in patients with cardiac implantable electronic devices: an overview of worldwide regulations. Expert Review of Medical Devices 2020;17:297-308. [DOI: 10.1080/17434440.2020.1742108] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
286 Plancke AM, Connolly A, Gemmell PM, Neic A, McSpadden LC, Whitaker J, O'Neill M, Rinaldi CA, Rajani R, Niederer SA, Plank G, Bishop MJ. Generation of a cohort of whole-torso cardiac models for assessing the utility of a novel computed shock vector efficiency metric for ICD optimisation. Comput Biol Med 2019;112:103368. [PMID: 31352217 DOI: 10.1016/j.compbiomed.2019.103368] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
287 Desai H, Aronow WS, Ahn C, Gandhi K, Hussain S, Lai HM, Sharma M, Frishman WH, Cohen M, Sorbera C. Risk factors for appropriate cardioverter-defibrillator shocks, inappropriate cardioverter-defibrillator shocks, and time to mortality in 549 patients with heart failure. Am J Cardiol 2010;105:1336-8. [PMID: 20403488 DOI: 10.1016/j.amjcard.2009.12.057] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
288 Ruwald AH, Bloch Thomsen PE, Gang U, Jørgensen RM, Huikuri HV, Jons C. New-onset atrial fibrillation predicts malignant arrhythmias in post–myocardial infarction patients—A Cardiac Arrhythmias and RIsk Stratification after acute Myocardial infarction (CARISMA) substudy. American Heart Journal 2013;166:855-863.e3. [DOI: 10.1016/j.ahj.2013.08.017] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
289 Ruwald MH, Ruwald AC, Johansen JB, Gislason G, Lindhardt TB, Nielsen JC, Torp-Pedersen C, Riahi S, Vinther M, Philbert BT. Temporal Incidence of Appropriate and Inappropriate Therapy and Mortality in Secondary Prevention ICD Patients by Cardiac Diagnosis. JACC Clin Electrophysiol 2021;7:781-92. [PMID: 33516705 DOI: 10.1016/j.jacep.2020.11.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
290 Kutyifa V, Daubert JP, Olshansky B, Huang DT, Zhang C, Ruwald AH, Mcnitt S, Zareba W, Moss AJ, Schuger C. Characterization and predictors of first and subsequent inappropriate ICD therapy by heart rate ranges: Result of the MADIT-RIT efficacy analysis. Heart Rhythm 2015;12:2030-7. [DOI: 10.1016/j.hrthm.2015.05.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
291 Verdino RJ. The Wearable Cardioverter-Defibrillator. Journal of the American College of Cardiology 2010;56:204-5. [DOI: 10.1016/j.jacc.2010.04.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
292 Amara N, Boveda S, Defaye P, Klug D, Treguer F, Amet D, Perier M, Gras D, Algalarrondo V, Bouzeman A, Piot O, Deharo J, Fauchier L, Babuty D, Bordachar P, Sadoul N, Marijon E, Leclercq C. Implantable cardioverter-defibrillator therapy among patients with non-ischaemic vs. ischaemic cardiomyopathy for primary prevention of sudden cardiac death. EP Europace 2017. [DOI: 10.1093/europace/euw379] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
293 Hohnloser SH, Israel CW. Current evidence base for use of the implantable cardioverter-defibrillator. Circulation. 2013;128:172-183. [PMID: 23836830 DOI: 10.1161/circulationaha.112.000547] [Cited by in Crossref: 26] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
294 Sullivan RM, Russo AM, Berg KC, Stolen KQ, Seth M, Perschbacher D, Day JD, Olshansky B. Arrhythmia rate distribution and tachyarrhythmia therapy in an ICD population: Results from the INTRINSIC RV trial. Heart Rhythm 2012;9:351-8. [DOI: 10.1016/j.hrthm.2011.10.018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
295 Perini AP, Kutyifa V, Veazie P, Daubert JP, Schuger C, Zareba W, McNitt S, Rosero S, Tompkins C, Padeletti L, Moss AJ. Effects of implantable cardioverter/defibrillator shock and antitachycardia pacing on anxiety and quality of life: A MADIT-RIT substudy. Am Heart J 2017;189:75-84. [PMID: 28625384 DOI: 10.1016/j.ahj.2017.03.009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
296 Ma C, Yin X, Xia Y, Li W, Gao L, Dai S, Yu X. Frequent inappropriate implantable cardioverter defibrillator therapy was determined to be dual atrioventricular nodal non-reentrant tachycardia: A case report. Medicine (Baltimore) 2021;100:e25370. [PMID: 33832121 DOI: 10.1097/MD.0000000000025370] [Reference Citation Analysis]
297 van Rees JB, Borleffs CJW, de Bie MK, Stijnen T, van Erven L, Bax JJ, Schalij MJ. Inappropriate Implantable Cardioverter-Defibrillator Shocks. Journal of the American College of Cardiology 2011;57:556-62. [DOI: 10.1016/j.jacc.2010.06.059] [Cited by in Crossref: 303] [Cited by in F6Publishing: 162] [Article Influence: 30.3] [Reference Citation Analysis]
298 Powell BD, Asirvatham SJ, Perschbacher DL, Jones PW, Cha Y, Cesario DA, Cao M, Gilliam Iii FR, Saxon LA. Noise, Artifact, and Oversensing Related Inappropriate ICD Shock Evaluation: ALTITUDE NOISE Study: NOISE, ARTIFACT, OVERSENSING ICD SHOCKS. Pacing and Clinical Electrophysiology 2012;35:863-9. [DOI: 10.1111/j.1540-8159.2012.03407.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 23] [Article Influence: 4.7] [Reference Citation Analysis]
299 Beau S, Greer S, Ellis CR, Keeney J, Asopa S, Arnold E, Fischer A. Performance of an ICD algorithm to detect lead noise and reduce inappropriate shocks. J Interv Card Electrophysiol 2016;45:225-32. [DOI: 10.1007/s10840-015-0081-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
300 Parsi A, Glavin M, Jones E, Byrne D. Prediction of paroxysmal atrial fibrillation using new heart rate variability features. Comput Biol Med 2021;133:104367. [PMID: 33866252 DOI: 10.1016/j.compbiomed.2021.104367] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
301 Sweeney MO, Sakaguchi S, Simons G, Machado C, Connett JE, Yang F. Response to the Center for Medicare & Medicaid Services coverage with evidence development request for primary prevention implantable cardioverter-defibrillators: Data from the OMNI study. Heart Rhythm 2012;9:1058-66. [DOI: 10.1016/j.hrthm.2012.02.027] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
302 Brisben A. How the S-ICD (subcutaneous implantable cardiac defibrillator) senses cardiac signals to minimize cardiac over-sensing and maximize rhythm discrimination. Journal of Electrocardiology 2018;51:S38-43. [DOI: 10.1016/j.jelectrocard.2018.08.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 3.3] [Reference Citation Analysis]
303 Brumberg GE, Kaseer B, Shah H, Saba S, Jain S. Biventricular Defibrillator Patients Have Higher Complication Rates after Revision of Recalled Leads: RECALLED LEAD REVISION COMPLICATIONS. Pacing and Clinical Electrophysiology 2012;35:665-71. [DOI: 10.1111/j.1540-8159.2012.03401.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
304 Bracke FA, Dekker LR, van der Voort PH, Meijer A. Primary prevention with the ICD in clinical practice: not as straightforward as the guidelines suggest? Neth Heart J 2009;17:107-10. [PMID: 19325902 DOI: 10.1007/BF03086228] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
305 Ploux S, Varma N, Strik M, Lazarus A, Bordachar P. Optimizing Implantable Cardioverter-Defibrillator Remote Monitoring: A Practical Guide. JACC Clin Electrophysiol 2017;3:315-28. [PMID: 29759443 DOI: 10.1016/j.jacep.2017.02.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
306 Kooiman KM, Knops RE, Olde Nordkamp L, Wilde AA, de Groot JR. Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: Implications for management. Heart Rhythm 2014;11:426-34. [DOI: 10.1016/j.hrthm.2013.12.007] [Cited by in Crossref: 87] [Cited by in F6Publishing: 49] [Article Influence: 12.4] [Reference Citation Analysis]
307 DeMazumder D, Lake DE, Cheng A, Moss TJ, Guallar E, Weiss RG, Jones SR, Tomaselli GF, Moorman JR. Dynamic analysis of cardiac rhythms for discriminating atrial fibrillation from lethal ventricular arrhythmias. Circ Arrhythm Electrophysiol 2013;6:555-61. [PMID: 23685539 DOI: 10.1161/CIRCEP.113.000034] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
308 Burger AL, Schmidinger H, Ristl R, Pezawas T. Appropriate and inappropriate therapy in patients with single- or multi-chamber implantable cardioverter-defibrillators. Hellenic Journal of Cardiology 2020;61:421-7. [DOI: 10.1016/j.hjc.2020.03.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
309 Burger AL, Schmidinger H, Ristl R, Pezawas T. Sex difference in inappropriate therapy and survival among 1471 implantable cardioverter-defibrillator recipients. J Cardiovasc Electrophysiol 2019;30:1620-5. [PMID: 31165550 DOI: 10.1111/jce.14003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
310 Kuck K, Bordachar P, Borggrefe M, Boriani G, Burri H, Leyva F, Schauerte P, Theuns D, Thibault B, Kirchhof P, Hasenfuss G, Dickstein K, Leclercq C, Linde C, Tavazzi L, Ruschitzka F; Document Reviewers. New devices in heart failure: an European Heart Rhythm Association report: Developed by the European Heart Rhythm Association; Endorsed by the Heart Failure Association. Europace 2013;16:109-28. [DOI: 10.1093/europace/eut311] [Cited by in Crossref: 43] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
311 Duncan E, Thomas G, Johns N, Pfeffer C, Appanna G, Shah N, Hunter R, Finlay M, Schilling RJ, Sporton S. Do Traditional VT Zones Improve Outcome in Primary Prevention ICD Patients?: DO TRADITIONAL VT ZONES IMPROVE OUTCOME IN PRIMARY PREVENTION ICD PATIENTS? Pacing and Clinical Electrophysiology 2010;33:1353-8. [DOI: 10.1111/j.1540-8159.2010.02859.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
312 Cronin B, Essandoh MK. Update on Cardiovascular Implantable Electronic Devices for Anesthesiologists. Journal of Cardiothoracic and Vascular Anesthesia 2018;32:1871-84. [DOI: 10.1053/j.jvca.2017.09.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
313 Vijgen J, Botto G, Camm J, Hoijer C, Jung W, Le Heuzey J, Lubinski A, Norekvål TM, Santomauro M, Schalij M, Schmid J, Vardas P. Consensus Statement: Consensus Statement of the European Heart Rhythm Association: Updated Recommendations for Driving by Patients with Implantable Cardioverter Defibrillators. European Journal of Cardiovascular Nursing 2010;9:3-14. [DOI: 10.1016/j.ejcnurse.2010.01.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
314 Korantzopoulos P, Liu T, Li L, Goudevenos JA, Li G. Implantable cardioverter defibrillator therapy in chronic kidney disease: a meta-analysis. Europace 2009;11:1469-75. [PMID: 19812050 DOI: 10.1093/europace/eup282] [Cited by in Crossref: 32] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
315 MacIntyre CJ, Sapp JL, Abdelwahab A, Al-Harbi M, Doucette S, Gray C, Gardner MJ, Parkash R. The Effect of Shock Burden on Heart Failure and Mortality. CJC Open 2019;1:161-7. [PMID: 32159102 DOI: 10.1016/j.cjco.2019.04.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
316 Anselme F, Moubarak G, Savouré A, Godin B, Borz B, Drouin-garraud V, Gay A. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders. Heart Rhythm 2013;10:1492-8. [DOI: 10.1016/j.hrthm.2013.06.020] [Cited by in Crossref: 83] [Cited by in F6Publishing: 56] [Article Influence: 10.4] [Reference Citation Analysis]
317 Scott PA, Silberbauer J, Mcdonagh TA, Murgatroyd FD. Impact of prolonged implantable cardioverter-defibrillator arrhythmia detection times on outcomes: A meta-analysis. Heart Rhythm 2014;11:828-35. [DOI: 10.1016/j.hrthm.2014.02.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
318 Cleland JG, Keshavarzi F, Pellicori P, Dicken B. Case Selection for Cardiac Resynchronization in Atrial Fibrillation. Heart Failure Clinics 2013;9:461-74. [DOI: 10.1016/j.hfc.2013.07.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
319 Park KH, Lee CH, Jung BC, Cho Y, Bae MH, Kim YN, Park HS, Han S, Lee YS, Hyun DW, Kim J, Kim DK, Cha TJ, Shin DG. Effectiveness of Implantable Cardioverter-Defibrillator Therapy for Heart Failure Patients according to Ischemic or Non-Ischemic Etiology in Korea. Korean Circ J 2017;47:72-81. [PMID: 28154594 DOI: 10.4070/kcj.2016.0242] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
320 Urzua Fresno CM, Folador L, Shalmon T, Hamad FMD, Singh SM, Karur GR, Tan NS, Mangat I, Kirpalani A, Chacko BR, Jimenez-Juan L, Yan AT, Deva DP. Prognostic value of cardiovascular magnetic resonance left ventricular volumetry and geometry in patients receiving an implantable cardioverter defibrillator. J Cardiovasc Magn Reson 2021;23:72. [PMID: 34108003 DOI: 10.1186/s12968-021-00768-7] [Reference Citation Analysis]
321 Sood N, Ruwald AH, Solomon S, Daubert JP, Mcnitt S, Polonsky B, Jons C, Clyne CA, Zareba W, Moss AJ. Association between myocardial substrate, implantable cardioverter defibrillator shocks and mortality in MADIT-CRT. European Heart Journal 2014;35:106-15. [DOI: 10.1093/eurheartj/eht451] [Cited by in Crossref: 44] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
322 Marine JE. Remote monitoring for prevention of inappropriate implantable cardioverter defibrillator shocks: is there no place like home? Europace 2008;11:409-11. [DOI: 10.1093/europace/eup009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]